Tilray v červnu klesla téměř o 19 % poté, co vydala nové akcie při swapu dluhu za akcie, snížil se jí cenový cíl a na konci měsíce oznámila akvizici HelloMD.
Tilray Brands (TLRY 1.60%) doesn't, to put it politely, have a history of pleasing its investors. That was well in evidence across June, as the company -- diversifying from its roots as a pure-play marijuana business -- fell into one of its more unattractive habits, announced a new acquisition, and saw an analyst cut his price target on the shares. The combination of these developments pushed Tilray's stock down by nearly 19% that month.
New shares for old notes Over the course of its existence, the chronically loss-making Tilray has often issued new shares in order to bolster its finances. Sure enough, on two separate days in June -- one close to the start of the month, and one at the end -- the company divulged chunky stock flotations. It minted just over 1.2 million new shares in the first, and an additional 2.6 million-plus in the second.
Image source: Getty Images.
What makes the pair something of a departure for Tilray is that they weren't effected to raise capital. Instead, they were the equity side of a debt-for-equity swap the company effected with holders of some of its convertible notes (i.e., debt securities that convert to stock under certain conditions) that pay interest of 5.2%. As notes are booked as debt on the balance sheet, with this financial engineering move Tilray retired roughly $18 million in debt.
That'll improve the balance sheet to a degree (the company had $284 million in long-term borrowings at the end of February) which is, of course, a positive development. What's not so positive is the pile of new shares, as one reason investors have been wary of Tilray is its frequent new share issues. At least the June pair isn't excessively dilutive; the company's outstanding share count topped 123 million.
Later in the month an analyst following Tilray, Bernstein SocGen Group's Nadine Sarwat, cut her price target on the stock. She reduced it quite substantially, to $6.50 per share from $10. She also maintained her rather lukewarm stance on its future, keeping her market perform (hold, in other words) recommendation intact.
On the second-to-last day of the month, Tilray announced its latest acquisition. It is now the owner of HelloMD, a telehealth and patient engagement company focused on medical cannabis.
It didn't disclose the financial terms of the deal, but did say it boosts the company's "direct-to-patient capabilities, creates a fully vertically integrated medical cannabis framework for Tilray in Canada, and advances its global medical cannabis growth strategy."
Today's Change
(
-1.60
%) $
-0.07
Current Price
$
4.31
More losses to come? I think that combination of share price issuance and new asset acquisition is dismaying for some investors. I'd imagine they're wondering why Tilray is effectively reducing its stock's value while opening its wallet for an acquisition.
That wouldn't be such a concern if the company showed signs of reversing its loss-making ways, but I'm not seeing much indication of this yet. Personally, I don't think this stock is a compelling buy right now.
Perplexity potvrdila, že plánuje používat nový procesor Vera od Nvidia. Nvidia chce z těchto čipů do konce fiskálního roku získat tržby ve výši 20 miliard USD.
An Nvidia Vera CPU compute tray on display at the sidelines of the Computex trade show in Taipei, Taiwan, June 3, 2026. REUTERS/Ann Wang/File Photo Purchase Licensing Rights, opens new tab
SAN FRANCISCO, July 7 (Reuters) - AI startup Perplexity on Tuesday confirmed it plans to use Nvidia's (NVDA.O), opens new tab new central processing units, as the chip giant works to broaden its market and take on entrenched players such as Intel (INTC.O), opens new tab and Advanced Micro Devices (AMD.O), opens new tab.
Nvidia has said it expects to generate $20 billion in sales from its "Vera" CPU, a more generic computing chip than its AI-specific offerings, by the end of this fiscal year. The Vera chips are part of Nvidia's efforts to diversify sales as artificial intelligence companies such as OpenAI and DeepSeek make their own AI chips.
The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here.
Nvidia is entering a crowded market for CPUs long dominated by Intel and AMD, who supply CPUs for everything from laptops to web servers. But many of those chips were designed before the rise of what are known as AI "agents" that can carry out complex tasks on their own after receiving instructions from their human users.
Unlike human users of CPUs, who take breaks between tasks, AI agents do not. Perplexity Vice President for Computer Enterprise and Infrastructure Nate Kupp said Nvidia's CPU carried out AI agent coding tasks about 1.5 times faster than traditional CPUs.
"Vera really stood out to us as just like a dead-on fit for a lot of the core workloads that we have," Kupp said in an interview.
Perplexity declined to disclose how many Nvidia CPUs it plans to buy. Nvidia has previously disclosed that OpenAI, Anthropic and Oracle plan to use its CPUs.
Reporting by Stephen Nellis in San Francisco Editing by Bill Berkrot
Our Standards: The Thomson Reuters Trust Principles., opens new tab
NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against First Solar, Inc. (“First Solar” or the “Company”) (NASDAQ: FSLR) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 26-cv-03787, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired First Solar securities between February 26, 2025 and February 24, 2026, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
If you are an investor who purchased or otherwise acquired First Solar securities during the Class Period, you have until August 24, 2026, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
[Click here for information about joining the class action]
First Solar is a solar technology company that provides photovoltaic (“PV”) solar energy solutions. First Solar manufactures and sells PV solar modules that convert sunlight into electricity. As relevant here, First Solar’s product offerings include its Series 6 Plus PV module, manufactured at facilities in locations including Malaysia and Vietnam.
At the outset of the Class Period, Defendants announced that First Solar would reduce production output of Series 6 modules at facilities in Malaysia and Vietnam in 2025, to account for circumstances including, inter alia, an “uncertain U.S. policy environment following the 2024 U.S. elections,” and “a supply and demand imbalance for Southeast Asian product”. Notwithstanding these circumstances, First Solar reassured investors that its primary market, the United States, enjoyed stable module prices.
Then, on April 2, 2025, United States (“U.S.”) President Donald J. Trump announced a series of “reciprocal” tariffs on U.S. imports from all countries, including rates of 24% and 46% on Malaysia and Vietnam, respectively, presenting a challenge to First Solar. These tariffs were subsequently reduced to 10%. Throughout the Class Period, Defendants continued to assure investors that the dynamic policy landscape presented a “long term favorable” for First Solar and actually “strengthened [its] relative position in the solar manufacturing industry”.
The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Defendants had overstated First Solar’s capacity to manage the impact of U.S. tariff policy on the Company’s business; (ii) Defendants understated the extent to which its responses to U.S. tariff policy, including the intentional underutilization of production facilities in Malaysia and Vietnam, and attempted relocation of production to the U.S., were likely to negatively impact First Solar’s projected performance in the 2026 fiscal year; and (iii) as a result, Defendants’ public statements were materially false and misleading at all relevant times.
The truth began to emerge on January 7, 2026, when Jefferies downgraded First Solar to Hold from Buy, noting that during 2025, the Company had lowered guidance, faced significant de-bookings and experienced margin compression through 2025. Jefferies also flagged that “[international] facilities remain a pain point while tariffs exist” and “underutilization at [international] facilities remains a concern.” The Jefferies analyst also predicted that First Solar’s deployment opportunities were likely to be more limited in 2026.
On this news, First Solar’s stock price fell $27.67 per share, or 10.29%, to close at $241.11 per share on January 7, 2026.
Then, on February 24, 2026, First Solar issued a press release “announc[ing] financial results for the fourth quarter and year ended December 31, 2025.” Among other items, First Solar announced earnings that missed expectations by a wide margin and issued lower-than-expected FY 2026 revenue guidance, citing customer headwinds such as permitting delays under the Trump administration. Following First Solar’s announcement, Baird Research downgraded its stock to Neutral from Outperform, citing “several question marks in forward outlook”.
On this news, First Solar’s stock price fell $33.09 per share, or 13.61%, to close at $210.12 per share on February 25, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
, /PRNewswire/ -- Realty Income Corporation (Realty Income, NYSE: O), The Monthly Dividend Company®, today announced that it has declared its 673rd consecutive common stock monthly dividend. The dividend amount of $0.2710 per share, representing an annualized amount of $3.252 per share, is payable on August 14, 2026 to stockholders of record as of July 31, 2026.
About Realty Income
Realty Income (NYSE: O), an S&P 500 company, is real estate partner to the world's leading companies®. Founded in 1969, we serve our clients as a full-service real estate capital provider. As of March 31, 2026, we have a portfolio of over 15,500 properties in all 50 U.S. states, the U.K., and eight other countries in Europe. We are known as "The Monthly Dividend Company®" and have a mission to invest in people and places to deliver dependable monthly dividends that increase over time. Since our founding, we have declared 673 consecutive monthly dividends and are a member of the S&P 500 Dividend Aristocrats® index for having increased our dividend for over 31 consecutive years. Additional information about the company can be found at www.realtyincome.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this press release, the words "estimate," "anticipate," "assume," "expect," "believe," "intend," "continue," "should," "may," "likely," "plan," "seek," and similar expressions are intended to identify forward-looking statements. Forward-looking statements include discussions of our business, strategy, plans, and the intentions of management including dividends and the amount, timing and payment thereof. Forward-looking statements are subject to risks, uncertainties, and assumptions about us which may cause our actual future results to differ materially from expected results. Some of the factors that could cause actual results to differ materially are, among others, our continued qualification as a real estate investment trust; general domestic and foreign business, economic, or financial conditions; competition; fluctuating interest and currency rates; inflation and its impact on our clients and us; access to debt and equity capital markets and other sources of funding (including the terms, structure and partners of such funding); volatility and uncertainty in the credit and financial markets; other risks inherent in real estate, private capital, credit and mezzanine investments, and joint ventures or co-investment ventures, including solvency, defaults under leases, bankruptcies, potential liability relating to environmental matters, illiquidity of real estate investments (including rights of first refusal or rights of first offer), and potential damages from natural disasters; impairments in the value of our real estate assets; volatility and changes in domestic and foreign laws and the application, enforcement or interpretation thereof (including with respect to tax laws and rates); property ownership through co-investment ventures, funds, joint ventures, partnerships and other arrangements which, among other things, may transfer or limit our control of the underlying investments; epidemics or pandemics; the loss of key personnel; the threat and outcome of any legal proceedings to which we are a party or which may occur in the future; acts of terrorism and war; and the anticipated benefits from mergers, acquisitions, co-investment ventures, funds, joint ventures, partnerships and other arrangements; and those additional risks and factors discussed in our reports filed with the U.S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are not guarantees of future plans and performance and speak only as of the date of this press release. Past operating results and performance are provided for informational purposes and are not a guarantee of future results. There can be no assurance that historical trends will continue. Actual plans and results may differ materially from what is expressed or forecasted in this press release and forecasts made in the forward-looking statements discussed in this press release may not materialize. We do not undertake any obligation to update forward-looking statements or publicly release the results of any forward-looking statements that may be made to reflect events or circumstances after the date these statements were made or to reflect the occurrence of unanticipated events.
Trumpův návrh rozpočtu na obranu pro fiskální rok 2027 počítá s 54,6 miliardy USD pro DAWG, což je meziročně zhruba o 24 000 % více a víc než rozpočet námořní pěchoty. Většina peněz míří do výzkumu a vývoje autonomních zbraní a dronů.
Buried inside President Trump’s Fiscal Year 2027 defense budget request sits a line item that dwarfs almost every other increase in the document. The Defense Autonomous Warfare Group (DAWG), a Pentagon office that stood up quietly late last year with an initial budget of roughly $225 to $226 million, is slated to receive $54.6 billion in FY2027. That works out to a roughly 24,000% year-over-year increase, or approximately 243x its prior year budget. The DAWG allocation now exceeds the entire Marine Corps budget request of $52.8 billion and represents nearly 15% of the entire $350 billion reconciliation package. Most investors have never heard of the program.
What DAWG Actually Is The Defense Autonomous Warfare Group is a newly created Pentagon organization designed to unify all US military drone and autonomous weapons programs under a single command structure. It absorbs and supersedes the Biden-era Replicator initiative, which aimed to field hundreds of thousands of one-way attack drones but ran into supply chain bottlenecks. Internal documents reportedly indicate intent to eventually elevate DAWG into a unified combatant command, effectively making it a new branch of the US military. Crucially, most of the $54.6 billion is directed toward research and development. This is a technology race.
Total drone and counter-drone spending in the FY2027 request reaches approximately $74 to $75 billion, tripling FY2026 spending levels. The Department of War’s own overview earmarks $53.6 billion for autonomous systems procurement, domestic production capability, and advanced capabilities, alongside $14.4 billion for counter-unmanned systems across 250+ sites. The budget was drawn up before Operation Epic Fury (the Iran war beginning February 28, 2026), meaning the ramp reflects long-term strategic competition with China.
The $1.5 Trillion Envelope President Trump has framed the broader ask directly: “our Military Budget for the year 2027 should not be $1 Trillion Dollars, but rather $1.5 Trillion Dollars.” That is a 42% increase over FY2026, the largest year-over-year defense spending increase in the post-WWII era. It includes $17.5 billion for Golden Dome missile defense, $65.8 billion in the Shipbuilding and Conversion, Navy appropriation supporting 18 battle force ships, and $102 billion for aircraft procurement and R&D. Against the S&P 500’s 10.17% year-to-date gain, defense names have lagged, creating a valuation gap versus fundamentals.
1. Kratos Defense & Security Solutions (KTOS) Kratos Defense & Security Solutions (NASDAQ:KTOS) is the most direct pure-play on DAWG. Its Valkyrie CCA drone and solid rocket motor lines drove Q1 FY26 revenue of $371.0M, up 22.6% year over year, with Unmanned Systems posting 30.9% organic growth and a 1.6x book-to-bill. CEO Eric DeMarco cited a “generational recapitalization of the U.S. defense industrial base underway.” Shares are down 29.47% year to date, and insider selling has been persistent.
2. AeroVironment (AVAV) AeroVironment (NASDAQ:AVAV | AVAV Price Prediction) is the leading US manufacturer of small and medium military drones, with Switchblade loitering munitions and Puma reconnaissance systems in the field. Q4 FY26 revenue of $1.977 billion trailing twelve months came alongside FY26 record bookings of $2.7B and a 1.4x book-to-bill. CEO Wahid Nawabi flagged “rising global demand across lethal and non-lethal drones, counter-UAS, space and advanced technologies.” Shares are down 26.89% year to date, with an analyst target price of $258.61.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Northrop Grumman didn't make the cut. Grab the names FREE today.
3. Palantir Technologies (PLTR) Palantir Technologies (NASDAQ:PLTR) supplies the AI decision layer for autonomous warfare. The DoW budget specifies $2.3 billion for the Maven Smart System (MSS) and Joint Fires Network, plus $46.0 billion for a multi-year sovereign AI Arsenal. Q1 2026 revenue grew 84.7% year over year, with US Government revenue up 84% to $687 million. The stock trades at 88x forward earnings, a premium that leaves little room for execution slips.
4. Northrop Grumman (NOC) Northrop Grumman (NYSE:NOC) is the broadest beneficiary across the request. Q1 2026 revenue of $9.88 billion grew 4.4%, with Aeronautics Systems swinging to operating income of $305 million on B-21 production expansion. Backlog stands at $95.61 billion. CEO Kathy Warden pointed to an “unprecedented global demand environment.” Northrop selected the Kratos Valkyrie as its CCA aircraft for MUX TACAIR, tying it into the DAWG portfolio. It pays a 1.68% dividend yield.
5. Huntington Ingalls Industries (HII) Huntington Ingalls Industries (NYSE:HII) is the pure-play on the shipbuilding line. Q1 2026 revenue of $3.10 billion grew 13.3%, led by Newport News Shipbuilding at $1.665 billion, up 19.3%. Backlog is $54 billion. CEO Chris Kastner noted “Shipbuilding throughput has continued to improve with meaningful year over year growth.” As sole prime for nuclear-powered carriers and one of two Virginia-class submarine builders, HII is structurally levered to the 18 battle force ships in the request.
The Critical Caveat The president’s annual budget is only a proposal, and Congress is free to reject it. Senate Budget Committee chair Sen. Lindsey Graham has already expressed skepticism about the $350 billion reconciliation portion, and Sen. Mitch McConnell called for “regular order appropriations” rather than reconciliation funding. The DAWG allocation is almost entirely R&D spending, so technology payoffs are measured in years or decades, not quarters. Independent analyses suggest the broader package could add $6.9 trillion to the national debt over 10 years when accounting for increased interest costs. Government shutdowns, continuing resolutions, and fixed-price cost overruns remain live risks across every name above.
The Strategic Shift Whether or not the full $54.6 billion survives Congress, the direction is unmistakable. The Pentagon just signaled the next era of American warfare with a 24,000% budget increase for a program most Americans cannot name. Autonomous systems, AI decision infrastructure, hypersonics, and hull steel are the four verticals absorbing the flows. KTOS, AVAV, PLTR, NOC, and HII sit closest to those pipes. Congressional passage risk is real, but the strategic realignment behind the number is already reshaping capital allocation across the defense industrial base.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Northrop Grumman didn't make the cut. Grab the names FREE today.
Amgen čelí sporům s FDA i s regulátory v Coloradu, ale autor tvrdí, že dopad na byznys i dividendu by byl malý. Ve 1. čtvrtletí tržby vzrostly o 6 % na 8,6 mld. USD a EPS o 4 % na 3,34 USD.
Amgen (AMGN +0.61%) has been grabbing headlines lately, and not always for the right reasons. The company is currently engaged in a battle with the U.S. Food and Drug Administration (FDA), which has demanded that the biotech pull Tavneos, a medicine for severe anti-neutrophil cytoplasmic autoantibody-associated vasculitis (a group of rare autoimmune inflammatory diseases), from the market. The FDA is claiming that Amgen manipulated clinical trial data.
Elsewhere, Amgen has been fighting off attempts by Colorado regulators to cap the annual price of its famous psoriatic arthritis drug, Enbrel. Amgen recently won a court victory in that battle, although it probably isn't completely over yet. With all that going on, some might worry about Amgen's business and ability to maintain its dividend program intact. Should investors seek out other dividend stocks?
Image source: The Motley Fool.
A resilient business Suppose Amgen loses its dispute with the FDA and is forced to take Tavneos out of the U.S. market. Let's also assume that Colorado regulators get their way and put a price cap on Enbrel. What effect would those setbacks have on the company's financial results? The answer is that the immediate impact will be fairly minimal. In the first quarter, Enbrel's revenue was $320 million, down 37% from the year-ago period. The medicine's sales are declining largely due to Medicare price-setting under the Inflation Reduction Act, a 2022 law that gave the U.S. Centers for Medicare & Medicaid Services the authority to negotiate the prices of some of the drugs it spends the most on.
Enbrel was targeted by the first round of negotiations. This means the medicine plays a little role in Amgen's long-term growth plans, especially since it will face biosimilar competition by 2029. Price setting at the state level would accelerate the year-over-year sales decline for the immunosuppressant, but it would do little to fundamentally change Amgen's prospects (although, in fairness, it may set a dangerous legal precedent).
Regarding Amgen having to pull Tavneos from the U.S. market, the medicine was first approved in 2021 and generated $119 million in sales in the first quarter, up 32% year over year. It accounted for just 1.4% of the company's total revenue. This loss also wouldn't be that big a deal. Amgen has proven, time and time again, that it can overcome obstacles of this kind. Last year, it lost patent exclusivity for denosumab, a bone health medicine marketed under brands such as Prolia and Xgeva.
It was a meaningful growth driver, but despite this loss, the company is still performing well. In the first quarter, Amgen's revenue increased 6% year over year to $8.6 billion, while its earnings per share rose 4% to $3.34. Amgen can also overcome the headwinds it is currently facing.
Today's Change
(
0.61
%) $
2.25
Current Price
$
368.69
Amgen's strong pipeline Another reason to be bullish about Amgen's future is the company's pipeline. The biotech is developing several important medicines to bolster its lineup and mitigate the potential negative impact of regulatory and legal setbacks. Perhaps Amgen's most promising candidate is MariTide, an investigational GLP-1 medicine that is being developed across diabetes, weight loss, sleep apnea, cardiovascular outcomes, and more. This drug, which is undergoing several phase 3 studies, could become a leading GLP-1 therapy, especially given its differentiated profile.
MariTide is being developed for once-monthly or less frequent administration. Even with lower weight-loss efficacy than some current options, it could attract many patients and carve out a solid niche in the fast-growing GLP-1 market. And again, it isn't the only exciting pipeline candidate in Amgen's portfolio. Amgen's ability to develop newer, better products to replace older ones whose sales are dropping is another reason the company's outlook is strong.
A strong dividend track record Amgen has a robust underlying business, is posting solid financial results, and boasts a deep pipeline. In addition to all that, the company's dividend track record is pretty impressive. Amgen has increased its payouts every year since it first initiated one in 2011 -- and over the past decade, its dividend has increased by 152%. Meanwhile, the company's forward yield is 2.7%, compared with the S&P 500's average of 1.1%. Amgen may be in the news for the wrong reasons, but the company's dividend remains as safe as ever. Long-term income seekers can still count on this company.
Conference call to be webcast live at 2 p.m. PT / 5 p.m. ET
, /PRNewswire/ -- Zillow Group, Inc. (Nasdaq: Z and ZG) today announced it will release second-quarter 2026 financial results after market close on Wednesday, Aug. 5, 2026. The company will host a webcast and conference call to discuss its results that afternoon at 2 p.m. PT / 5 p.m. ET.
Information about Zillow Group's financial results, including a link to the live webcast and recorded replay, will be available on the company's Investor Relations website at https://investors.zillowgroup.com/investors/financials/quarterly-results/default.aspx.
Please register for the live event here.
For more information about Zillow Group, visit https://investors.zillowgroup.com.
About Zillow Group:
Zillow Group, Inc. (Nasdaq: Z and ZG) is reimagining real estate to make home a reality for more and more people.
As the most visited real estate app and website in the United States, Zillow connects hundreds of millions of consumers with innovative technology, trusted agents and loan officers, and seamless digital solutions. With industry-leading tools and resources, Zillow supercharges real estate professionals so they can grow their businesses and deliver exceptional client experiences. For renters and housing providers, Zillow offers not only a robust marketplace but a set of end-to-end products and services to streamline applications, leases, payments and more.
Zillow's ecosystem spans the entire home journey — from dreaming and shopping to renting, buying, selling and financing.
Zillow Group's affiliates, subsidiaries and brands include Zillow®, Zillow Premier Agent®, Zillow Home Loans®, Zillow Rentals®, Zillow® New Construction, Trulia®, StreetEasy®, Out East®, HotPads®, Follow Up Boss®, ShowingTime®, dotloop® and Zillow® Closing.
Akcie Eli Lilly v úterý ráno vzrostly o 2,63 % poté, co Jim Cramer odmítl názor, že příběh Mounjara už skončil. JPMorgan vidí další potenciál v mezinárodním růstu a na americkém trhu s obezitou.
Drug stocks got hit hard on Monday in what Jim Cramer called a “vicious rotation,” and the selloff looked like the usual crowded-trade unwind. Investors decided the Mounjaro story was played out. On Tuesday morning’s Mad Dash, Cramer walked through why he thinks that reading is wrong, and he had a fresh JPMorgan note flagging “potential upside from Mounjaro international” and U.S. obesity-market growth “much higher than people think” to lean on.
Eli Lilly (NYSE:LLY | LLY Price Prediction) closed Monday at $1,200.06 and was rallying 2.63% on Tuesday as Cramer defended it.
Why the Crowd Thinks It’s Over The played-out thesis has surface merit. Lilly is a $1.16 trillion market cap trading at 44x trailing earnings and 33x forward, the stock has run 59% in the past year, and realized prices on Mounjaro and Zepbound went down 13% last quarter as rebates and market-access deals bit into gross margin.
Reddit sentiment turned bearish from late June onward, with retail chatter dominated by presidential-stock-promotion drama and a “weight loss race” framing that has Novo Nordisk asking suppliers for discounts to try to regain share. So the story going into August is that the easy money has been made, generic GLP-1 competition is coming, and pricing goes only one way from here.
Cramer’s Three-Part Bull Case Cramer’s rebuttal is a runway argument in three parts. First, most of the world isn’t on these drugs yet. The numbers back it. Mounjaro did $8.66 billion in Q1 2026, up 125% year over year, with international revenue growing 81% as China added it to the National Reimbursed Drug List. When you pair a doubling in volume with fresh reimbursement in the world’s second-largest economy, you get a curve that looks nothing like a mature product.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Eli Lilly didn't make the cut. Grab the names FREE today.
Second, the pill. Cramer called an oral formulation “radical.” The FDA already approved Foundayo (orforglipron), the only GLP-1 pill that can be taken any time of day without food or water restrictions, and it beat oral semaglutide head to head in The Lancet. Every needle-averse patient, every emerging-market pharmacy without cold-chain distribution, every employer benefits manager choking on injectable pricing suddenly becomes addressable. The GLP-1 total addressable market expands the moment the pill hits shelves.
Third, muscle-sparing. Cramer called losing fat without losing muscle the “holy grail” of the category, and he is right that it is the differentiator that matters for the second wave. Retatrutide, Lilly’s next-gen triple agonist, delivered weight loss up to 71.2 lbs with osteoarthritis pain relief in prior trials. If you are the doctor writing scripts three years from now, you write the one that keeps the patient strong.
The August Earnings Catalyst and the Setup Risk Lilly reports again in the first week of August. The setup is straightforward. Management already raised 2026 guidance to $82.0 to $85.0 billion in revenue and $35.50 to $37.00 in non-GAAP EPS, and the company has beaten estimates four straight quarters, including a 25.88% EPS beat last quarter (see the Q1 2026 8-K). Cramer’s read of the JPMorgan note is that it is the first analyst signal of a positive surprise coming.
The risk is exactly what makes the bull case attractive. A stock trading at a full multiple, up double digits into the earnings report, needs the international ramp and the Foundayo launch numbers to actually land. If oral scripts start slower than the Street models, or if Novo’s rebate war compresses net pricing again, the reaction is asymmetric to the downside. Cramer is likely right that “played out” is the wrong frame for a company still adding countries, formulations, and mechanisms. Whether he is right about the next four weeks is a separate question, and the answer arrives in early August.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Eli Lilly didn't make the cut. Grab the names FREE today.
First Majestic uzavřel definitivní dohodu o prodeji dolu San Martin za celkem 90 milionů USD. Z toho 2,5 milionu USD má přijít při uzavření a zbytek, tedy 87,5 milionu USD, v budoucích platbách.
Vancouver, British Columbia--(Newsfile Corp. - July 7, 2026) - First Majestic Silver Corp. (NYSE: AG) (TSX: AG) (FSE: FMV) (the "Company" or "First Majestic") is pleased to announce that it has entered into a definitive agreement (the "Agreement") dated July 6, 2026 to sell its 100%-owned past producing San Martin Silver Mine located 250 kilometres north of Guadalajara city in Jalisco State, Mexico, in the San Martin de Bolaños mining district, ("San Martin"), to Flextronics Supply and Service, S. de R.L. de C.V ("Flextronics"), a private Mexican company, for total cash consideration of US$90 million (the "Transaction"), comprised of upfront consideration of US$2.5 million payable upon closing of the Transaction (US$500,000 of this amount has already been deposited into escrow as a deposit), and an additional US$87.5 million in future payments.
TRANSACTION DETAILS
The Agreement provides that, subject to satisfaction and waiver of certain conditions described below, Flextronics will acquire all of the issued and outstanding shares of Minera El Pilon, S.A. de C.V. ("El Pilon"), a wholly-owned subsidiary of First Majestic incorporated under the laws of Mexico that holds a 100% interest in San Martin. The acquisition also includes the Jalisco Group of Properties, consisting of 5,245 hectares of mining concessions owned by El Pilon, and located in the municipalities of Etzatlán and Tototlán, Jalisco. In exchange, Flextronics is required to make the following payments to First Majestic:
US$2.5 million in cash at closing (US$500,000 of this amount has already been deposited into escrow as a deposit);US$2.5 million in cash within 180 days of closing; US$10 million in cash on each anniversary date of closing, commencing on the first anniversary of closing and continuing each subsequent anniversary thereafter until and including the fifth anniversary date of closing (by which time, a total of $US50.0 million in anniversary payments would have been paid);US$35.0 million on August 31, 2032.Closing of the Transaction is subject to customary closing conditions, as well as Mexican Antitrust approval. First Majestic anticipates that the Transaction will close in the fourth quarter of 2026.
The San Martin Silver Mine is a past producing silver and gold operation that was placed under care and maintenance by First Majestic in July 2019. Flextronics is part of Meridian Capital, a diversified investment group focused on the mining and oil & gas sectors, with development projects across Mexico, including Sonora and Sinaloa, as well as in Venezuela and Uruguay.
ABOUT FIRST MAJESTIC
First Majestic is a publicly traded mining company focused on silver and gold production in Mexico and the United States. The Company presently owns and operates four producing underground mines in Mexico: the Santa Elena Silver/Gold Mine, the Los Gatos Silver Mine (the Company holds a 70% interest in the Los Gatos Joint Venture that owns and operates the mine), the San Dimas Silver/Gold Mine, and the La Encantada Silver Mine, as well as a portfolio of development and exploration assets, including the Jerritt Canyon Gold project located in northeastern Nevada, U.S.A.
First Majestic is proud to own and operate its own minting facility, First Mint, LLC, and to offer a portion of its silver production for sale to the public. Bars, ingots, coins and medallions are available for purchase online at www.firstmint.com, at some of the lowest premiums available.
This news release contains "forward‐looking information" and "forward-looking statements" under applicable Canadian and U.S. securities laws (collectively, "forward‐looking statements"). These statements relate to future events or the Company's future performance, business prospects or opportunities that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management made in light of management's experience and perception of historical trends, current conditions and expected future developments. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives or future events or performance (often, but not always, using words or phrases such as "seek", "anticipate", "plan", "continue", "estimate", "expect", "may", "will", "project", "predict", "forecast", "potential", "target", "intend", "could", "might", "should", "believe" and similar expressions) are not statements of historical fact and may be "forward‐looking statements". Forward-looking statements include, but are not limited to: completion of the Transaction; all future payments due after closing of the Transaction; the satisfaction and waiver of certain closing conditions, including the receipt of Mexican Antitrust approval and the timing for such approval; and the expected timing of closing of the Transaction. These statements are based on the Company's assumptions that all conditions to closing of the Transaction will be satisfied in a timely manner. These assumptions may prove to be incorrect and actual results may differ materially from those anticipated. Actual results may vary from forward-looking statements.
Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results to materially differ from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the parties' ability to satisfy the conditions of closing of the Transaction, as well as those factors discussed in the section entitled "Risk Factors" in the Company's most recent Annual Information Form for the year ended December 31, 2025 filed with the Canadian securities regulatory authorities under the Company's SEDAR+ profile at www.sedarplus.ca, and in the Company's Annual Report on Form 40-F for the year ended December 31, 2025 filed with the United States Securities and Exchange Commission on EDGAR at www.sec.gov/edgar. Although First Majestic has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. The Company believes that the expectations reflected in these forward‐looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking statements included herein should not be unduly relied upon. These statements speak only as of the date hereof. The Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by applicable laws.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304329
Source: First Majestic Silver Corp.
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
DraftKings posiluje po spuštění DKeX, vlastní burzy pro prediction markets, která má rozšířit nabídku kontraktů. Firma zároveň uvedla roční objem sázek zákazníků kolem 3,4 miliardy USD a celkový objem obchodů zhruba 11,3 miliardy USD.
DraftKings shares are powering higher. What’s fueling DKNG momentum? What Is Driving DraftKings’ New DKeX Exchange?DraftKings is deepening its push into prediction markets with DKeX, a proprietary exchange built to support a more differentiated DraftKings Predictions experience and expand the range of event contracts available on its platform.
The rollout comes as DraftKings Predictions gains traction, with the company reporting about $3.4 billion in annualized consumer volume for the week ended June 21 and roughly $11.3 billion in annualized total trading volume. That scale is one reason traders are viewing DKeX as more than a routine product update, but as a move toward greater vertical integration.
The launch also comes as the prediction-markets space grows more competitive. Meta is reportedly developing a standalone app internally called "Arena," raising questions about whether new entrants could eventually pressure user engagement, pricing power and market share.
DraftKings Stock: Key Levels To WatchAt $26.98, the stock is trading above its 20-day SMA ($26.52), 50-day SMA ($25.37), and 100-day SMA ($24.41), which keeps the intermediate trend pointed up after the April swing low. The bigger-picture hurdle is still the 200-day SMA ($28.87), with shares trading 5.7% below that long-term trend line after a weaker 12-month run (down 32.85%).
MACD is the cleaner momentum read right now: it’s below its signal line with a negative histogram, which typically means upside pressure is cooling unless buyers can reassert control. In plain terms, MACD tracks trend momentum, and being below the signal line often shows the recent upswing is losing steam rather than accelerating.
Key Resistance: $30.00 — a round-number area that can act as an overhead supply zone as price works back toward longer-term resistance Key Support: $23.50 — a nearby floor that lines up with a prior buyer-defense zone and sits below the 50-day/100-day averages as a "trend break" tell What Is DraftKings and How Does It Operate?DraftKings got its start in 2012 as an innovator in daily fantasy sports, then expanded into online sports and casino gambling after the 2018 Supreme Court ruling that opened the door for state-by-state legalization. Today it generally holds the number-two or -three revenue share position across states where it competes, giving it scale benefits in a market where product depth and pricing can drive retention.
DraftKings Earnings Preview: What Analysts ExpectLooking further out, the next major catalyst for the stock arrives with the August 5, 2026 (estimated) earnings report.
EPS Estimate: 28 cents (Down from 38 cents YoY) Revenue Estimate: $1.56 Billion (Up from $1.51 Billion YoY) Valuation: P/E of 291.2x (Indicates premium valuation) Analyst Consensus & Recent Actions: The stock carries a Buy rating with an average price target of $35.13 (high $50.00, low $27.00) across 50 analysts. Recent analyst moves include:
Susquehanna: Positive (Lowers Target to $31.00) (July 1) Citizens: Market Outperform (Raises Target to $36.00) (June 25) Guggenheim: Buy (Maintains Target to $35.00) (June 24) DraftKings Benzinga Edge Rankings ExplainedBelow is the Benzinga Edge scorecard for DraftKings, highlighting its strengths and weaknesses compared to the broader market:
The Verdict: DraftKings’ Benzinga Edge signal reveals a premium-valued setup with only moderate growth support and still-weak momentum characteristics. For longer-term bulls, the cleaner technical tell is whether price can reclaim the 200-day area; for risk control, $23.50 is the nearby level that would start to undermine the current uptrend structure.
DraftKings Stock Price Action on TuesdayDKNG Stock Price Activity: DraftKings shares were up 2.75% at $26.93 at the time of publication on Tuesday, according to Benzinga Pro data.
Image: Shutterstock
Market News and Data brought to you by Benzinga APIs
FuelCell Energy oznámila zahájení upsané veřejné nabídky akcií za 200 milionů USD. Výnosy chce použít na kapitálové výdaje související s rozšířením výrobní kapacity na podporu růstu, provozní kapitál a obecné firemní účely.
July 07, 2026 16:05 ET | Source: FuelCell Energy, Inc.
DANBURY, Conn., July 07, 2026 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (NASDAQ: FCEL) today announced the launch of an underwritten public offering of $200 million of shares of its common stock (the “Offering”). All of the shares are being offered by FuelCell Energy. FuelCell Energy expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock sold in the offering at the public offering price, less underwriting discounts and commissions. FuelCell Energy intends to use the net proceeds from the Offering, if completed, for capital expenditures related to expansion of manufacturing capacity to support growth, working capital and general corporate purposes. The Offering is subject to market conditions and other factors, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.
Citigroup and Barclays are acting as joint book-running managers for the Offering.
A shelf registration statement on Form S-3 (333-296607) relating to these securities has been filed with the Securities and Exchange Commission (“SEC”) and became automatically effective on June 8, 2026. The Offering may be made only by means of a prospectus supplement and accompanying prospectus. A preliminary prospectus supplement relating to and describing the terms of the Offering will be filed with the SEC and copies of the preliminary prospectus supplement relating to the Offering may be obtained for free by visiting the SEC’s website at www.sec.gov. When available, copies of the preliminary prospectus supplement and the accompanying prospectus may also be obtained by contacting: Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 (Tel: 800-831-9146) and Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-888-603-5847 or by e-mail at [email protected]. The final terms of the Offering will be disclosed in a final prospectus supplement to be filed with the SEC.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any offer, solicitation or sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Forward-Looking Statements
This press release contains statements that the Company believes to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). All statements other than statements of historical fact included in this press release are forward-looking statements. Words such as “expects,” “anticipates,” “estimates,” “goals,” “projects,” “intends,” “plans,” “believes,” “predicts,” “should,” “seeks,” “will,” “could,” “would,” “may,” “forecast,” and similar expressions and variations of such words are intended to identify forward-looking statements and are included, along with this statement, for purposes of complying with the safe harbor provisions of the PSLRA. These forward-looking statements include, but are not limited to, statements about FuelCell Energy’s proposed public offering and FuelCell Energy’s intention to grant the underwriters an option to purchase additional shares. Forward-looking statements are neither historical facts, nor assurances of future performance. Instead, such statements are based only on our beliefs, expectations, and assumptions regarding the future. The forward-looking statements contained in this press release are subject to risks and uncertainties, known and unknown, that could cause actual results and future events to differ materially from those set forth in or contemplated by the forward-looking statements, including, without limitation, risks and uncertainties related to, among other things, market conditions and the demand for FuelCell Energy’s securities. These and other risks are described in greater detail under the section titled “Risk Factors” contained in the preliminary prospectus supplement and the accompanying prospectus, the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q and the Company’s other filings with the SEC. Any forward-looking statements that the Company makes in this press release are made pursuant to the PSLRA and speak only as of the date of this press release. Except as required by law, the Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
About FuelCell Energy
FuelCell Energy, Inc. (Nasdaq: FCEL) is an American clean energy technology company delivering continuous, scalable baseload power for mission-critical applications globally. The Company’s fuel cell systems generate electricity directly at the point of use, enabling reliable, low-emissions power for data centers, industrial facilities, utilities, and distributed generation customers. FuelCell Energy delivers commercially proven, modular, utility-scale systems backed by global fuel cell deployments.
Rocket Lab oznámila úspěch mise VICTUS HAZE pro U.S. Space Force a splnila všechny fáze rychleji, než byly stanovené lhůty. Start přišel za 16 hodin a 42 minut po výzvě k odstartování.
LONG BEACH, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB), a global leader in launch services and space systems, today announced mission success for its role in the U.S. Space Force’s (USSF) VICTUS HAZE mission.
This historic mission required Rocket Lab to design, build, and test a Pioneer spacecraft for the USSF, launch it on Electron within 24 hours’ notice, commission the spacecraft within 72 hours, and then conduct complex rendezvous and proximity operations (RPO) on orbit within 84 hours to pursue, monitor, approach, and photograph another target satellite in a demonstration of a rapid threat-response scenario.
Rocket Lab successfully completed all mission phases faster than the deadlines set by the Space Force, setting records and delivering new standards in responsive space.
Responsive Launch: On June 19th, Rocket Lab launched the VICTUS HAZE mission just 16 hours and 42 minutes after receiving the Notice To Launch from the Space Force - the fastest response time ever for a Tactically Responsive Space (TacRS) mission.Spacecraft Commissioning: Completed within 38 hours – more than 30 hours ahead of the Space Force’s 72-hour deadline – Rocket Lab’s spacecraft operation team methodically activated and verified all of Pioneer’s systems including power, communications, and attitude control, ensuring the satellite was fully operational and ready to begin its tactical space domain awareness mission. RPO Operations: Completed in less than 59 hours – 25 hours ahead of the Space Force’s 84-hour deadline. Rocket Lab’s Pioneer spacecraft performed a series of complex orbital maneuvers to pursue, monitor, approach, and photograph a target satellite on orbit. Throughout operations, Rocket Lab maintained continuous tracking of the target spacecraft, demonstrating precision navigation and control capabilities essential for space domain awareness operations. While traditional missions have relied on separate contractors for rockets, satellites, and operations in space, Rocket Lab is delivering all three for VICTUS HAZE – the first time a single prime contractor has provided an entire all-in-one mission for the TacRS program.
Rocket Lab founder and CEO, Sir Peter Beck, says: “Rocket Lab has set the new standard in responsive space with VICTUS HAZE. Delivering a fully integrated and complete mission capability when the clock is ticking is a proud moment for the Rocket Lab team in a long history of delivering mission success for the United States and its allies. Now that the primary mission is complete, we look forward to continuing to push Pioneer on orbit under new and complex Space Force task orders to deliver new capabilities.”
Deployed by the USSF’s Space Systems Command (SSC), led by the Space Safari Program Office, in partnership with the Defense Innovation Unit (DIU), VICTUS HAZE is a Tactically Responsive Space (TacRS) mission generating the vital data, technology, and real-world operational experience needed to make that rapid response a repeatable reality.
With the threshold RPO demonstration now successfully completed, Rocket Lab will continue to operate the Pioneer spacecraft on orbit for several more months to prove out additional advanced RPO tactics, techniques, and procedures tasked by Space Safari.
Rocket Lab’s continued successful delivery of responsive space missions and increasingly complex RPO mission objectives for the USSF reinforces the Company’s reputation as a trusted partner capable of executing the most challenging and time-critical missions for national security.
About Rocket Lab
Rocket Lab is a leading space company providing launch services, spacecraft, payloads, and satellite components to commercial, government, and national security customers. Rocket Lab's Electron rocket is the world's most frequently launched orbital small rocket; its HASTE rocket provides hypersonic test launch capability for the U.S. government and allied nations; and its Neutron launch vehicle in development will unlock medium launch for constellation deployment, national security, and exploration missions. Rocket Lab is publicly listed on the Nasdaq stock exchange (RKLB). Learn more at www.rocketlabcorp.com
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development, operational expansion and business strategy, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the “SEC”), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at https://investors.rocketlabcorp.com which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
Wave Life Sciences získala souhlas akcionářů k redomicilaci do USA a čeká na schválení Singapurským nejvyšším soudem. Slyšení je naplánováno na 14. července 2026.
July 07, 2026 16:15 ET | Source: Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- As previously announced, Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“Wave” or “Wave Life Sciences”), has obtained the requisite shareholder approval required in connection with its proposed redomiciliation (“Redomiciliation”) to the United States by way of the implementation of a statutory procedure known as a scheme of arrangement under Section 210 of the Companies Act 1967 of Singapore (the “Scheme of Arrangement”). The Scheme of Arrangement remains subject to approval by the High Court of the Republic of Singapore (the “Singapore Court”).
Wave has made an application to the Singapore Court to approve the Scheme of Arrangement, as filed in HC/SUM 2058/2026 in HC/OA 434/2026 in the Singapore Court on July 1, 2026 (Singapore Time), and the application has been directed to be heard before the Singapore Court on July 14, 2026 at 2:30 pm (Singapore Time), at Chamber 2A of the Supreme Court of Singapore at 1 Supreme Court Lane, Singapore 178879. The Singapore Court has directed that any affidavits in response to the application must be submitted to the Singapore Court by 4:00 pm (Singapore Time) on July 8, 2026, and that any written submissions and bundles of authorities must be filed with and tendered to the Singapore Court by 4:00 pm (Singapore Time) on July 10, 2026.
A copy of the materials filed with the application and the related directions provided by the Singapore Court will be made available under the Corporate Governance section of our Investor Relations website.
About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave’s PRISM® platform combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities, including RNAi (SpiNA) and RNA editing (AIMers), provides Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Wave’s pipeline is focused on its obesity (WVE-007), alpha-1 antitrypsin deficiency (WVE-006) and PNPLA3 I148M liver disease (WVE-008) programs, and also includes clinical programs in Duchenne muscular dystrophy and Huntington’s disease, as well as several preclinical programs utilizing the company’s versatile RNA medicines platform. Driven by the calling to “Reimagine Possible,” Wave is leading the charge toward a world in which human potential is no longer hindered by the burden of disease. Wave is headquartered in Cambridge, MA. For more information on Wave’s science, pipeline and people, please visit www.wavelifesciences.com and follow Wave on X and LinkedIn.
Some of the statements included in this announcement may include “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, in particular, statements about our expectations regarding the change of the parent company of the group from a Singapore company to a Delaware corporation. These statements include, but are not limited to, statements that address our expected future business and statements about the Redomiciliation and other statements identified by words such as “will”, “expect”, “believe”, “anticipate”, “estimate”, “should”, “intend”, “plan”, “potential”, “predict”, “project”, “aim”, and similar words, phrases or expressions. These forward-looking statements are based on current expectations and beliefs of the management of Wave Life Sciences, as well as assumptions made by, and information currently available to, such management, current market trends and market conditions and involve risks and uncertainties, many of which are outside Wave Life Sciences’ and management’s control, and which may cause actual results to differ materially from those contained in forward looking statements. Accordingly, you should not place undue reliance on such statements.
Particular uncertainties that could materially affect future results include risks associated with the Redomiciliation, including our ability to obtain shareholder and Singapore High Court approvals and satisfy other closing conditions to the completion of the Redomiciliation within the expected timeframe or at all; our ability to realize the expected benefits from the Redomiciliation; the occurrence of difficulties or material timing delays in connection with the Redomiciliation, including any unanticipated costs in connection therewith; any delays, challenges and expenses associated with receiving governmental and regulatory approvals; changes in tax laws, tax treaties or tax regulations or the interpretation or enforcement thereof by the tax authorities in Singapore, the United States and other jurisdictions following the Redomiciliation; our critical accounting policies; the ability of our preclinical studies to produce data sufficient to support the filing of global clinical trial applications and the timing thereof; our ability to continue to build and maintain the company infrastructure and personnel needed to achieve our goals; the clinical results and timing of our programs, which may not support further development of our product candidates; actions of regulatory agencies, which may affect the initiation, timing and progress of clinical trials; our effectiveness in managing current and future clinical trials and regulatory processes; the success of our platform in identifying viable candidates; the continued development and acceptance of nucleic acid therapeutics as a class of drugs; our ability to demonstrate the therapeutic benefits of our stereopure candidates in clinical trials, including our ability to develop candidates across multiple therapeutic modalities; our ability to obtain, maintain and protect intellectual property; our ability to enforce our patents against infringers and defend our patent portfolio against challenges from third parties; our ability to fund our operations and to raise additional capital as needed; competition from others developing therapies for similar uses; and any impacts on our business as a result of or related to any local and global health epidemics, geopolitical conflicts, global economic uncertainty, the impact of tariffs and changes in economic policies, volatility in inflation, volatility in interest rates or market disruptions on our business.
The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are set forth in our definitive proxy statement filed on May 7, 2026 and our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and the other documents that we file with the SEC, including under the heading “Risk Factors” in our most recent Annual Report on Form 10-K. You may obtain copies of these documents as described under the heading “Additional Information and Where to Find It.”
Our filings with the Securities and Exchange Commission (“SEC”), which you may obtain without charge at the SEC’s website at http://www.sec.gov, discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no intent or obligation to publicly update or revise any of these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Investors:
James Salierno
Director, Investor Relations
+1 617-949-4043 [email protected]
Microchip těží z rostoucí poptávky po mixed-signal MCU; ty tvořily téměř 50 % tržeb fiskálního 2026. Bookings sílí, book-to-bill zůstává nad jednou a duben byl nejsilnější za téměř čtyři roky.
Key Takeaways MCHP is positioned to gain from rising mixed-signal MCU demand across industrial and auto markets.Mixed-signal MCUs made up nearly 50% of fiscal 2026 revenue, supporting long-term growth.Bookings improved, book-to-bill stayed above one and April marked the strongest month in nearly four years. Microchip Technology (MCHP - Free Report) is well positioned to benefit from the growing demand for mixed-signal microcontrollers (MCUs), leveraging its expanding footprint in industrial embedded control, broad product portfolio and total system solutions strategy. Mixed-signal MCUs remain the company's largest product category, accounting for nearly 50% of fiscal 2026 revenues, highlighting their importance to long-term growth.
The company is witnessing renewed demand across its key MCU-driven markets, including industrial automation, automotive, aerospace & defense, communications and AI-enabled data centers. MCHP management noted that innovation-driven growth has resumed as customers restart new product development after working through excess inventories. These new designs increasingly require intelligent mixed-signal MCUs capable of integrating analog, connectivity, security and real-time control functions into a single platform. Microchip highlighted particularly strong innovation activity in industrial automation, automotive, aerospace & defense and data center applications.
Microchip’s leadership in mixed-signal MCUs is further strengthened by its Total System Solutions strategy. Rather than selling standalone microcontrollers, the company bundles MCUs with analog ICs, power management, connectivity, timing, security and FPGA products, increasing content per design win and making its platforms more attractive for customers. The company continues to maintain strong attach rates while expanding reference designs that encourage customers to adopt more Microchip components within a single system, supporting higher long-term revenue per application.
The company’s diversified customer base and long product life cycles also provide resilience. Mixed-signal MCU demand is recovering across thousands of customers as inventories normalize, while bookings have strengthened, book-to-bill remains above one, and April represented the strongest booking month in nearly four years. Microchip expects nearly all business units, including its microcontroller franchise, to participate in the ongoing recovery, supported by broad-based demand across industrial, automotive, aerospace & defense and data center markets.
MCHP Faces Tough CompetitionMicrochip is facing significant competition from the likes of Texas Instruments (TXN - Free Report) and Analog Devices (ADI - Free Report) .
Texas Instruments competes directly with Microchip by expanding its embedded processing portfolio around MCU targeting industrial, automotive and power applications. Management emphasized that Texas Instruments is shifting its embedded business toward a broader MCU portfolio with integrated analog peripherals, application-specific MCUs, motor control, power conversion, connectivity and radar capabilities. The planned acquisition of Silicon Labs further strengthens its wireless MCU offerings, particularly for industrial IoT, giving Texas Instruments a broader embedded portfolio that competes directly with Microchip's mixed-signal MCU franchise.
Analog Devices competes with Microchip in embedded processing by combining high-performance mixed-signal technologies with embedded intelligence for industrial and automotive applications. Rather than offering standalone MCUs, Analog Devices integrates sensing, signal-chain, power management, connectivity and software to enable edge intelligence for digital factories, robotics, healthcare and automotive systems. This allows ADI to address complex embedded control applications where precision analog performance and real-time processing are critical, competing directly with Microchip's higher-end mixed-signal MCU portfolio.
MCHP’s Share Price Performance, Valuation & EstimatesShares of Microchip have appreciated 37.4% year to date, outperforming the broader Zacks Computer and Technology sector’s rise of 16.6%.
MCHP Stock’s Price Performance
Image Source: Zacks Investment Research
The MCHP stock is trading at a premium, with a forward 12-month price/earnings of 26.35X compared with the broader sector’s 24.98X. Microchip has a Value Score of D.
MCHP’s Valuation
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Microchip’s fiscal 2027 earnings is currently pegged at $3.09 per share, up by a penny over the past 30 days, suggesting 88.4% growth from the fiscal 2026’s reported figure.
Microchip currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
AppLovin v 1. čtvrtletí 2026 vykázal rekordní tržby ve výši 1,84 miliardy USD, což je meziročně o 59 % více. Akcie přesto od začátku roku klesly zhruba o 19 %.
Key Takeaways APP delivered record Q1 2026 revenues of $1.84 billion, up 59% year over year.AppLovin posted an 85% adjusted EBITDA margin and a 65% net margin in its latest quarter.APP trades at premium valuation multiples, supporting a hold stance despite strong fundamentals. Despite delivering strong operational performance, AppLovin (APP - Free Report) has seen its stock decline roughly 19% year to date. The weakness reflects shifting market sentiment toward high-growth technology stocks rather than any visible deterioration in the company’s fundamentals. While investors have grown cautious about valuation and broader macroeconomic uncertainty, AppLovin continues to execute at a remarkably high level.
Image Source: Zacks Investment Research
The company remains one of the fastest-growing names in digital advertising, supported by artificial intelligence-driven ad optimization, expanding monetization capabilities and improving profitability. As the stock trades well below its recent highs, investors may need to determine whether the recent correction reflects a fundamental concern or simply a disconnect between price action and business performance.
AI-Powered Advertising Continues to Drive APP’s Revenue GrowthAppLovin’s growth story remains firmly intact, with demand for its AI-powered advertising and app monetization platform continuing to accelerate.
Quarterly revenues climbed steadily from $406 million in the second quarter of 2023 to nearly $1 billion by the fourth quarter of 2024. The momentum strengthened further throughout 2025, with quarterly revenues consistently exceeding $1 billion while maintaining sequential growth.
The company carried that momentum into the first quarter of 2026, reporting record quarterly revenues of $1.84 billion, representing an impressive 59% year-over-year increase.
This sustained expansion reflects increasing adoption of AppLovin’s AI-enhanced advertising solutions, particularly improvements driven by its Axon platform. The company has also broadened its reach beyond its traditional gaming customer base into larger e-commerce and digital advertising markets, creating new opportunities for long-term expansion.
As advertisers increasingly rely on AI-powered targeting, campaign optimization and monetization tools to improve returns on advertising spend, AppLovin continues to strengthen its position within one of the fastest-growing segments of the digital advertising industry.
Margin Expansion Is Becoming APP’s StrengthAlthough rapid revenue growth continues to attract investor attention, AppLovin’s profitability may represent its greatest long-term strength.
The company is increasingly generating revenue from higher-margin software offerings, allowing a much larger percentage of incremental sales to flow directly to the bottom line. This favorable business mix, combined with disciplined cost management, has significantly improved operating efficiency over the past several quarters.
During its latest reported quarter, AppLovin delivered an adjusted EBITDA margin of 85%, expanding 100 basis points from the prior-year period. Net margin improved even more dramatically, rising 1,500 basis points to 65%.
These figures demonstrate that AppLovin is not merely growing rapidly; it is scaling efficiently. Many technology companies can deliver strong top-line expansion, but far fewer can convert that growth into substantial profitability.
The company’s operating leverage suggests its business model becomes increasingly profitable as revenues continue to expand, reinforcing the quality and durability of its earnings profile.
Analyst Projections Signal Fundamental StrengthAnalyst expectations reflect continued optimism. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $3.72 per share, indicating a 65% increase from the year-ago period. Revenue for the same quarter is expected to reach $1.94 billion, indicating 54% year-over-year growth. Looking further ahead, full-year 2026 earnings are projected to increase 59%, with 2027 earnings expected to rise an additional 32%. Revenues are also expected to increase 42% in 2026 and 29.5% in 2027. These projections underscore confidence in the company’s monetization engine and its ability to deliver strong earnings amid digital ad market expansion.
APP Valuation Appears ElevatedAPP currently trades at a forward P/E multiple of 29.29, noticeably above the industry average of 22.11.
Image Source: Zacks Investment Research
Its forward price-to-sales ratio of 19.21 also stands far above the industry benchmark of 2.89, indicating that investor expectations for future growth remain extremely aggressive.
Image Source: Zacks Investment Research
When stocks trade at premium valuation levels, even modest growth slowdowns or softer guidance can lead to significant multiple compression. Consequently, APP shares could remain vulnerable if market sentiment shifts or expectations are revised lower.
Comparing APP With Major U.S. Advertising Technology RivalsThe Trade Desk (TTD - Free Report) operates a demand-side advertising platform centered around programmatic advertising and advanced audience targeting capabilities. Although The Trade Desk benefits from strong exposure to premium advertising brands, its profitability profile tends to be more cyclical and sensitive to broader advertising spending trends compared with AppLovin. While TTD prioritizes scale and reach, AppLovin remains more focused on performance optimization and monetization efficiency.
Unity Software (U - Free Report) also maintains exposure to digital advertising through its real-time 3D platform and monetization offerings. However, Unity Software’s advertising operations remain closely connected to developer ecosystems and have historically demonstrated greater volatility. Unlike AppLovin, Unity Software continues to balance profitability objectives alongside growth expansion, making AppLovin’s consistent margin profile a notable competitive advantage among peers.
Hold Rating Appears AppropriateAppLovin continues to execute exceptionally well, supported by robust demand for its AI-powered advertising platform, expanding profitability, and favorable long-term growth prospects. The company has consistently demonstrated its ability to scale efficiently while strengthening its competitive position across the digital advertising ecosystem. However, much of this optimism appears reflected in the stock's premium valuation, leaving limited room for disappointment if growth moderates or market sentiment weakens. Although the long-term outlook remains compelling, the current risk-reward profile suggests investors should adopt a wait-and-watch approach. APP appears appropriately rated as a Hold while investors monitor future execution and valuation trends.
APP carries a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks Rank #1 (Strong Buy) stocks here.
Super Micro Computer je za měsíc níž o 36 % a obchoduje se kolem 26 USD, zatímco trh zpochybňuje kvalitu jeho ziskovosti z AI serverů. Tržby za 3. čtvrtletí sice meziročně vzrostly o 123 %, ale marže zůstává jen 11 %.
Shares of Super Micro Computer (NASDAQ:SMCI | SMCI Price Prediction) are changing hands at $26 and change midday on Tuesday, capping a punishing stretch that has left the stock down 36% over the past month. The AI server maker has become the clear laggard of the datacenter hardware group, even as spending on AI infrastructure continues at a record pace.
For contrast, Hewlett Packard Enterprise (NYSE:HPE) stock is down 11% over the same stretch, while Dell Technologies (NYSE:DELL) stock has actually gained 7%. That three-way divergence has opened up a striking valuation gap and revived the debate over whether Super Micro Computer stock is a bargain or a classic value trap.
The core question for investors: does a P/E ratio near 14x reflect genuine mispricing, or the market’s growing skepticism about the durability of Super Micro Computer’s AI-server earnings?
What’s Behind the Selloff The pressure intensified after Super Micro Computer reported its Q3 FY2026 results on May 5. Non-GAAP EPS of $0.84 beat estimates, but revenue of $10.24 billion came in missing expectations, and the company noted results were preliminary and unaudited pending a board review.
Retail sentiment turned sharply negative in June. A WallStreetBets thread titled “SMCI dropped 28% today” drew over 2,242 upvotes, and Reddit sentiment scores for Super Micro Computer stayed in bearish territory through the balance of the month.
The pattern in the sentiment data was notable. Even as Super Micro Computer shares kept falling, dip-buying chatter never materialized, suggesting retail investors were treating the decline as risk-off rather than opportunity.
Peers Tell a Different Story Dell Technologies stock has surged 237% year to date, powered by $16.13 billion in AI-optimized server revenue last quarter and a $24.4 billion AI order backlog. Dell Technologies stock trades at a P/E ratio of 34x, a premium the market has been willing to pay for scale and execution.
Hewlett Packard Enterprise stock is up 83% year to date on the strength of the Juniper integration, with server revenue climbing 33% last quarter. Hewlett Packard Enterprise stock now trades at a P/E ratio of 41x, the richest multiple in the group.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Dell Technologies didn't make the cut. Grab the names FREE today.
Super Micro Computer stock, by contrast, is down 9% year to date despite comparable exposure to the same AI capex wave. The valuation spread against Dell Technologies and Hewlett Packard Enterprise is now wide enough to force a decision.
Value Prospect or Value Trap? The bull case for Super Micro Computer is straightforward. Shares have already absorbed a heavy round of bad news, the P/E ratio sits well below peers, and Q3 FY2026 revenue still grew 123% year over year. CEO Charles Liang asserted that “Supermicro’s transformation into a total datacenter infrastructure provider is accelerating,” pointing to margin recovery and new U.S. manufacturing capacity in Silicon Valley.
The bear case is equally credible. Super Micro Computer’s gross margin sits at 11%, thin for a hardware maker, and AI servers are commoditizing as Dell Technologies and Hewlett Packard Enterprise press their scale advantages. A cheap multiple can stay cheap for a long time if the market questions earnings quality, and Super Micro Computer stock carries a beta of 1.94, meaning volatility cuts both ways.
Investors considering a contrarian entry should consider keeping their position sizes modest given the swings in Super Micro Computer stock and the concentrated risks in its customer base and margin profile.
What to Watch Next The setup is genuinely mixed. Super Micro Computer offers the cheapest exposure in the group to AI infrastructure spending, but the discount exists for reasons the market has been pricing in over months. Whether that gap closes depends largely on execution.
The next catalysts are Super Micro Computer’s Q4 FY2026 results and any update on the board’s independent review. Investors can watch for whether SMCI shares hold recent lows at $26 into the next earnings report, and whether guidance in the $11.0 billion to $12.5 billion range can be defended without further margin compression.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Dell Technologies didn't make the cut. Grab the names FREE today.
FormFactor těží z prudkého růstu poptávky po AI infrastruktuře, hlavně po HBM, GPU a síťových čipech. Firma čeká další rekordní čtvrtletí u DRAM probe cards.
Key Takeaways FormFactor is gaining from AI demand for probe cards, HBM testing, GPUs, ASICs and networking chips.Record DRAM probe card revenues were driven by HBM demand, with another record quarter expected.CPO adoption, Triton systems and Keystone Photonics are expected to support long-term FORM growth. FormFactor (FORM - Free Report) is benefiting from the rapid expansion of AI infrastructure, leveraging its leadership in semiconductor probe cards and wafer-level testing technologies. As hyperscalers and chipmakers invest heavily in AI servers, the demand for high-bandwidth memory (HBM), GPUs, networking chips and custom AI accelerators continues to rise, significantly increasing the need for advanced semiconductor testing solutions.
The company is positioned at the intersection of high-performance computing (HPC) and advanced packaging, two of the fastest-growing segments of the semiconductor industry. FormFactor highlighted record revenues from DRAM probe cards, driven by strong HBM demand, while networking applications also delivered robust growth. FormFactor expects another record quarter for DRAM probe cards as customers accelerate the transition from HBM3 to HBM4 and eventually HBM5. The company's proprietary SmartMatrix technology enables simultaneous testing of hundreds of HBM stacks at HBM4 speeds, giving it a competitive advantage as AI memory complexity increases.
AI infrastructure demand is also expanding opportunities beyond memory. FormFactor is seeing increasing demand for probe cards used in networking processors, data center CPUs, GPUs and custom ASICs. Management noted that networking growth helped a leading high-performance computing customer become a 10% customer for the first time, while GPU production qualification is nearing completion, with volume shipments expected in the second half of 2026. The company is also deepening engagements with hyperscalers developing custom AI chips.
FormFactor is also benefiting from the emergence of co-packaged optics (CPO), an important AI networking technology. The company raised its 2026 CPO revenue outlook toward the high end of the previously guided $10-$20 million range, citing faster production ramps and growing demand for Triton production-test systems developed with Advantest and Tokyo Electron. Through its Triton production-test platform and Keystone Photonics acquisition, FORM expects accelerating CPO adoption to become another long-term growth driver. At its Investor Day, FORM management projected that strong demand across HBM, GPUs, networking, custom ASICs and CPO would help double revenue by 2030 while supporting continued market share gains in AI infrastructure.
FORM Faces Tough CompetitionFormFactor is facing significant competition from the likes of Teradyne (TER - Free Report) and Cohu (COHU - Free Report) .
Teradyne’s leadership in automated test equipment (ATE) is a key catalyst. As AI chip production accelerates, Teradyne’s UltraFLEX and UltraFLEXplus platforms are widely used to test high-performance GPUs, AI accelerators, networking processors and advanced data center semiconductors from leading chipmakers. The company continues to benefit from rising test complexity as larger AI processors require more sophisticated and longer testing cycles. Teradyne’s strong relationships with major semiconductor manufacturers and a broad installed base make it a key player in AI semiconductor manufacturing.
Cohu’s offering of semiconductor test handlers, contactors, interface products and inspection solutions that support the production of AI processors, networking chips and high-performance computing devices has been a major driver. The company has been expanding its capabilities in advanced packaging and high-performance test applications, enabling customers to improve throughput, automation and yield as AI semiconductor complexity continues to increase. Cohu's broad portfolio allows it to participate across multiple stages of semiconductor testing, particularly in high-volume manufacturing environments.
FORM’s Share Price Performance, Valuation & EstimatesShares of FormFactor have appreciated 97.3% year to date, outperforming the broader Zacks Computer and Technology sector’s rise of 16.6%.
FORM Stock’s Price Performance
Image Source: Zacks Investment Research
The FORM stock is trading at a premium, with a forward 12-month price/earnings of 47.26X compared with the broader sector’s 24.98X. FormFactor has a Value Score of F.
FORM’s Valuation
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for FORM’s 2026 earnings is currently pegged at $2.40 per share, unchanged over the past 30 days, suggesting 84.6% growth from 2025’s reported figure.
FormFactor currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Chewy uvádí, že růst opakovaných tržeb táhne vyšší počet aktivních zákazníků i vyšší útrata na zákazníka. Kliniky Chewy Vet Care přivádějí nové klienty a posilují loajalitu v ekosystému Autoship.
Key Takeaways Chewy's recurring revenues are supported by customer growth and higher spending per active customer.CHWY's Vet Care clinics attract new customers and help increase spending from existing customers.CHWY's Autoship ecosystem and value proposition continue to support loyalty and market share gains. Chewy, Inc. (CHWY - Free Report) highlighted the continued strength of its recurring revenue base, supported by a balanced contribution from both active customer growth and the Net Sales Per Active Customer (NSPAC) expansion. Management believes that the pet category remains resilient, supported by recurring non-discretionary spending and strong emotional attachment between pet owners and their pets. Despite a more challenging operating environment, the company continues to gain market share steadily within the category.
The company views Chewy Health and Chewy Vet Care to be among its most significant long-term growth opportunities. Chewy Vet Care clinics continue to deliver strong stand-alone economics while supporting customer acquisition and retention across the broader Chewy ecosystem. Around 40% of clinic customers are new to Chewy and generate approximately $900 in first-year NSPAC. In addition, existing Chewy customers who visit Chewy Vet Care increase their share of wallet at a meaningfully faster rate after their initial clinic visit.
Chewy’s value proposition continues to differentiate it through industry-leading convenience, competitive pricing, trusted service, a broad product assortment and its recurring Autoship ecosystem. Management noted that these strengths become even more relevant during periods when consumers prioritize value, reliability and trusted relationships. The company believes this combination reinforces customer loyalty, supports sustained demand and strengthens its competitive positioning within the pet category.
Overall, Chewy’s integrated ecosystem continues to strengthen its competitive position by deepening customer relationships and increasing customer lifetime value. Consistent execution of this strategy should support durable market share gains and sustainable long-term profitable growth.
Zacks Rundown for CHWYCHWY shares have lost 32.3% in the past six months compared with the industry’s 7.6% decline. The company carries a Zacks Rank #5 (Strong Sell) at present.
Image Source: Zacks Investment Research
From a valuation standpoint, CHWY trades at a forward price-to-earnings ratio of 22.77, higher than the industry’s average of 21.38.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for earnings for the current and next fiscal year indicates year-over-year growth of 20.5% and 21.7%, respectively.
Image Source: Zacks Investment Research
Stocks to ConsiderSome better-ranked stocks have been discussed below:
Central Garden & Pet Company (CENT - Free Report) produces and distributes various products for the lawn and garden, and pet supplies markets in the United States. It currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for CENT’s current financial-year sales implies a decline of 5.7%, and the same for earnings implies growth of 5.9% from the year-ago reported numbers. CENT delivered a trailing four-quarter earnings surprise of 45.4%, on average.
Phibro Animal Health Corporation (PAHC - Free Report) operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. PAHC presently carries a Zacks Rank of 2 (Buy).
The Zacks Consensus Estimate for PAHC's current fiscal-year sales and earnings implies growth of 14.8% and 47.4%, respectively, from the year-ago actuals. PAHC delivered a trailing four-quarter earnings surprise of 16.3%, on average.
Trupanion, Inc. (TRUP - Free Report) together with its subsidiaries, provides medical insurance for cats and dogs on a subscription basis in the United States, Canada, Continental Europe, and Australia. It currently holds a Zacks Rank #2.
The Zacks Consensus Estimate for TRUP’s current financial-year sales and earnings indicates 9.4% and 20% growth from the last year, respectively. TRUP reported a trailing four-quarter average earnings surprise of 250%.
DigitalOcean čeká ve 2. čtvrtletí meziroční růst tržeb o 29 %, zatímco upravená EBITDA marže i non-GAAP zisk na akcii míří na horní hranici výhledu. Akcie DOCN byly v úterý výše o 7,85 %.
DigitalOcean Holdings shares are climbing with conviction. What’s behind DOCN gains? Revenue Outlook Raises Questions About the Sustainability of Recent GrowthThe headline figure is a 29% year-over-year revenue increase expected for the second-quarter period, a dramatic step up from the 14% expansion the business delivered in the second quarter of 2025. Alongside the top-line beat the company said profitability metrics are also tracking ahead of plan with adjusted EBITDA margin and non-GAAP net income per share both on pace to finish at or beyond the upper boundary of guidance issued earlier this year.
DigitalOcean’s AI Customer Momentum Is AcceleratingCEO Paddy Srinivasan said customers are gravitating toward the platform because of its purpose-built architecture for inference and agentic applications and the cost advantages it offers over providers that simply rent out GPU hardware without the surrounding software layer.
DigitalOcean Expands Data Center Capacity to Meet DemandOn the infrastructure side the company locked in an additional 20 megawatts of data center space scheduled to become operational across late 2027 and early 2028 lifting its total secured capacity to around 155 megawatts. Management said conversations about securing further capacity beyond that are ongoing.
The stronger business trajectory is also expected to push the company’s full year revenue exit rate above what it had previously projected with specifics to be shared when formal quarterly results are released.
DOCN Shares Are JumpingDOCN Price Action: DigitalOcean shares were up 7.85% at $141.69 at the time of publication on Tuesday, according to Benzinga Pro.
Image: Shutterstock
Market News and Data brought to you by Benzinga APIs
SoFi v 1. čtvrtletí 2026 přidala rekordních 1,1 milionu členů na 14,7 milionu a počet produktů vzrostl o 39 % na 22,2 milionu. Nástroj AI Coach v testu přiměl téměř 70 % aktivních uživatelů k finanční akci.
Key Takeaways SoFi added 1.1M members in Q1 2026, reaching 14.7M, while products rose 39% year over year.SOFI Coach helped nearly 70% of engaged test members take meaningful financial actions in early testing.Composer by SoFi lets investors build, test and automate rules-based strategies using natural language. SoFi Technologies (SOFI - Free Report) is leaning harder into AI as it turns its “everything app” into a more active financial hub. In the first quarter of 2026, the company added a record 1.1 million members, reaching 14.7 million, while products rose 39% year over year to 22.2 million. Cross-buy reached 43%, showing that more members are using multiple SoFi products.
That matters because SoFi’s model depends on deeper relationships, not just one-time account openings. Management calls this the Financial Services Productivity Loop, where brand awareness brings in members, more products build trust and higher lifetime value supports innovation. In the first quarter, unaided brand awareness hit 10%, showing that the platform is gaining visibility.
SoFi Coach fits into that plan. The AI chat tool helps members track spending, manage debt, plan goals and take next steps in the SoFi app. In early testing, nearly 70% of engaged test members took actions such as paying down debt or moving money into higher-yield accounts.
Composer by SoFi focuses on investing. The platform lets investors build, test and automate rules-based strategies. Users can create custom strategies, explore more than 2,000 community-built strategies or combine approaches into diversified portfolios while keeping control over rules and inputs.
The AI push comes as SoFi is already showing strong financial momentum. First-quarter 2026 adjusted net revenues rose 41% to $1.1 billion and adjusted EBITDA increased 62% to $340 million. If Coach drives daily engagement and Composer expands investing usage, AI could become a practical growth layer for SOFI’s member ecosystem.
How Are Other Competitors Faring?Upstart (UPST - Free Report) remains the most direct AI-driven lending peer to SOFI. Its proprietary models assess credit risk, detect fraud, price loans and support expansion into auto and home lending. The company says AI remains its growth engine despite profit pressure. In the first quarter of 2026, 91% of loans on Upstart’s platform were fully automated, with no human intervention.
Happen, Inc. (HAPN - Free Report) , formerly LendingClub, operates Happen Bank and positions itself primarily as a digital bank. It uses AI, machine learning and data-driven underwriting to support credit decisions, risk assessment and loan pricing. Its rebranding reflects a shift beyond marketplace lending toward a broader digital banking platform. In first-quarter 2026, it generated $2.7 billion in loan originations, up 31% year over year.
SOFI’s Price Performance, Valuation, and EstimatesShares of SOFI have gained 9% in the past three months, outperforming the broader industry but underperforming the S&P 500 Index.
Image Source: Zacks Investment Research
From a valuation standpoint, SOFI trades at a forward price-to-earnings ratio of 26.67X, well above the industry’s 9.80X. It carries a Value Score of F.
Image Source: Zacks Investment Research
SOFI’s estimates have remained unchanged over the past month. The Zacks Consensus Estimate for full-year 2026 EPS is pegged at 59 cents.
Image Source: Zacks Investment Research
SOFI stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Sterling Infrastructure ve 1. čtvrtletí zvýšila tržby o 92 % a upravený EPS o 120 %, zároveň zvedla celoroční výhled. Akcie za rok vystřelily o 215,9 %.
Key Takeaways Sterling shares surged 215.9% in a year, far outpacing the industry, sector and S&P 500.STRL's first-quarter revenues jumped 92%, adjusted EPS rose 120%, and full-year guidance increased.Sterling's record backlog and E-Infrastructure growth support visibility into future project demand. Sterling Infrastructure (STRL - Free Report) has been one of the top-performing infrastructure stocks over the past year, with its shares soaring 215.9%. The rally has far outpaced the Zacks Engineering - R&D Services industry's 36.8% gain, the Zacks Construction sector's 18.9% increase and the S&P 500's 23.9% return. Investors have rewarded the company for delivering outstanding financial performance while successfully positioning itself at the center of several long-term infrastructure trends, including AI-driven data centers, semiconductor manufacturing and mission-critical construction.
STRL Price Performance (1 Year)
Image Source: Zacks Investment Research
The sharp rise in the stock, however, has pushed Sterling's valuation above the industry average. The stock currently trades at a forward 12-month price-to-earnings (P/E) multiple of 31.76X compared with the industry average of 29.8X. While the premium is not excessive, it raises an important question for investors: Does Sterling's business outlook justify paying more for the stock, or has most of its future growth already been reflected in the current share price?
STRL Valuation vs Industry - P/E (F12M)
Image Source: Zacks Investment Research
Sterling's latest operating performance suggests the premium may still be supported. The company continues to report record earnings, rapidly expanding backlog and improving guidance, while analysts remain overwhelmingly bullish on its long-term prospects.
Sterling's Growth Story Remains StrongSterling's investment case continues to be supported by powerful earnings momentum and growing exposure to some of the fastest-growing infrastructure markets.
The company's first-quarter 2026 performance demonstrated that demand remains exceptionally strong. Revenues surged 92% year over year, while adjusted earnings per share jumped 120%. Adjusted EBITDA more than doubled, supported by expanding margins and strong execution across large infrastructure projects. Following these results, management raised its full-year guidance, expecting revenues between $3.7 billion and $3.8 billion and adjusted earnings per share (EPS) of $18.40-$19.05.
Analysts have become increasingly optimistic as well. Over the past 60 days, the Zacks Consensus Estimate for 2026 earnings has increased to $19.12 per share from $13.65, reflecting expected growth of 75.7% from 2025. Revenues are projected to climb 59.2% in 2026, followed by another 29.1% increase in 2027, while EPS is expected to grow another 35.1%.
STRL EPS Estimate Revision Trend
Image Source: Zacks Investment Research
Wall Street also remains highly positive on the stock. Sterling carries an Average Brokerage Recommendation (ABR) of 1.00, with all nine covering analysts rating the shares a Strong Buy. The average price target of $945.71 suggests roughly 32% upside from current levels.
Image Source: Zacks Investment Research
Data Centers & Semiconductors Drive Long-Term OpportunityThe biggest driver of Sterling's future growth continues to be its rapidly expanding E-Infrastructure business.
First-quarter E-Infrastructure revenues increased 174%, while adjusted operating income climbed 177%, benefiting from continued investment in data centers and other mission-critical projects. Management noted that more than 90% of the segment's backlog now comes from mission-critical projects, including data centers, advanced manufacturing and semiconductor facilities.
The company also secured the initial phase of a large semiconductor fabrication campus during the quarter. Management believes this award represents only the beginning of a much larger semiconductor opportunity expected to accelerate later this decade. Sterling also continues expanding into new geographic markets as hyperscale customers increase investments across Texas, the Midwest and the Pacific Northwest.
Another important advantage is Sterling's growing ability to provide both site development and electrical services through the CEC acquisition. Management said that cross-selling opportunities are materializing much faster than originally expected, allowing the company to secure integrated contracts that improve productivity while supporting future margin expansion.
STRL’s Backlog and Acquisitions Provide Better VisibilitySterling's record backlog provides another reason for investor confidence. Signed backlog reached $3.8 billion at the end of the first quarter, up 78% year over year, while combined backlog climbed 131% to $5.15 billion. Including unsigned awards and future project phases, Sterling now has visibility into nearly $6.5 billion of future work. Management believes increasing project size, complexity and duration continues to strengthen long-term earnings visibility.
The company is also using acquisitions to expand both its capabilities and geographic reach. After successfully integrating CEC, Sterling recently acquired Stone Ridge Contracting, strengthening its site development operations across the Pacific Northwest and Texas. Stone Ridge is expected to generate between $180 million and $200 million of revenues during 2026 while further expanding Sterling's presence in high-growth data center and industrial markets.
Strong cash generation and a healthy balance sheet provide additional flexibility to pursue further acquisitions while continuing share repurchases.
Premium Valuation Leaves Less Room for ErrorAlthough Sterling's long-term outlook remains attractive, investors should recognize that expectations have become much higher following the stock's remarkable rally.
At 31.76X forward earnings, Sterling trades above the industry average. Such a valuation requires the company to continue delivering exceptional execution, sustained earnings growth and steady margin expansion.
The Building Solutions segment also remains under pressure. While first-quarter revenues improved modestly, management continues to expect residential construction markets to remain challenging throughout 2026 because of affordability pressures.
In addition, Sterling's growth increasingly depends on continued investment in AI infrastructure, hyperscale data centers and semiconductor manufacturing. Any slowdown in these capital spending trends, project delays or weaker customer investment could reduce future growth expectations. Likewise, integrating acquisitions while maintaining industry-leading margins across rapidly expanding operations remains an ongoing execution challenge.
Sterling vs. Its CompetitorsSterling competes with EMCOR Group (EME - Free Report) , MasTec (MTZ - Free Report) and Granite Construction (GVA - Free Report) across data centers, utilities, transportation and other large infrastructure projects.
Sterling has significantly outperformed all three competitors over the past year, with its 215.9% gain comfortably exceeding MasTec's 126.3% increase, Granite Construction's 60.2% rise and EMCOR's 45.5% advance. The superior stock performance reflects Sterling's faster earnings growth and increasing exposure to AI-related infrastructure spending.
Valuation tells a balanced story. Sterling's forward P/E multiple of 31.76X sits above EMCOR's 25.27X but below MasTec's 36.18X, while Granite Construction trades at a lower valuation than Sterling. EMCOR offers investors a less expensive alternative with strong execution, MasTec commands the richest valuation because of its own infrastructure growth prospects, while Granite Construction provides steadier exposure to traditional public infrastructure markets. Sterling appears reasonably valued relative to its expected growth and sits between the lower-risk EMCOR and the higher-valued MasTec.
Is STRL Stock Still a Buy?Sterling is no longer a bargain after more than tripling over the past year, but its premium valuation appears supported by equally impressive business momentum.
The company continues benefiting from favorable long-term trends in AI infrastructure, hyperscale data centers, semiconductor manufacturing and advanced industrial construction. Record backlog, rising analyst estimates, expanding margins, disciplined capital allocation and strategic acquisitions further strengthen its growth outlook.
While investors should expect occasional volatility after such a strong rally, Sterling's improving fundamentals suggest its growth story remains intact. Backed by a Zacks Rank #1 (Strong Buy), the stock still appears capable of delivering further upside for long-term investors, even while trading at a modest premium to the industry. You can see the complete list of today’s Zacks #1 Rank stocks here.
Key Takeaways Werner trades at a discount forward P/S ratio compared to its industry average, signaling a cheap valuation.Werner has a consistent track record of paying out dividends since 1987. WERN stock has gained in the past three months, and outperforms its industry and peers like ODFL and KNX. Werner Enterprises, Inc. (WERN - Free Report) looks cheap from a valuation standpoint. Considering the forward 12-month price-to-sales ratio (P/S-F12M), Werner is trading at a discount compared to the industry.
The stock has a forward 12-month P/S-F12M of 0.70X compared with 2.66X for the industry over the past five years. The company’s forward 12-month P/S-F12M ratio is also below the median level of 0.74X over the past five years. These factors indicate that the stock’s valuation is attractive. WERN has a Value Score of A.
Werner P/S Ratio (Forward 12 Months) Vs. Industry Image Source: Zacks Investment Research
Now, the question is whether it is worth buying, holding, or selling the Werner stock at current prices. Let us delve deeper to find out.
Tailwinds Working in Favor of Werner StockWerner's top line continues to benefit from strength across both its Truckload Transportation Services segment and Logistics segment. The company stands strong on the back of its dedicated revenue and fleet size growth, FirstFleet acquisition, improving rates and a robust 95% customer retention rate. Restructuring in its One-Way Truckload business has also helped WERN witness a rise in revenue per truck. Growth in Intermodal and Final Mile is aiding Logistics revenues. With constant cost reduction efforts and focus on safety, service and innovation, Werner is hopeful of delivering improved financial results as market conditions tighten throughout the year.
WERN’s solid balance sheet increases financial flexibility. The company ended first-quarter 2026 with cash and cash equivalents of $61.54 million, higher than the current debt level of $8.60 million. This implies that the company has sufficient cash to meet its current debt obligations.
Further, Werner’s current ratio (a measure of liquidity) at the end of first-quarter 2026 stood at 1.44, which is higher than the industry's reading of 1.10. The favorable comparison with respect to the current ratio looks encouraging. This may imply that the risk of default is less. Also, a current ratio greater than 1.0 is usually considered good for a company.
A strong balance sheet enables the company to reward shareholders with dividends and share repurchases. WERN has a consistent track record of paying out dividends since 1987. Dividend-paying stocks like WERN are generally safe bets for creating wealth, as these payouts act as a hedge against economic uncertainty. As a reflection of its shareholder-friendly stance, in 2022, WERN paid dividends of $32.1 million and repurchased shares worth $110.4 million. In 2023, WERN paid dividends of $34.20 million (did not repurchase any shares). In 2024, WERN paid dividends of $35.1 million and repurchased shares worth $67.1 million.
During 2025, WERN paid dividends of $34.1 million and repurchased shares worth $55.5 million. As of March 31, 2026, WERN had 5.0 million shares remaining under its share repurchase authorization. Such shareholder-friendly initiatives should boost investor confidence and positively impact the bottom line.
WERN Stock’s Price PerformanceShares of WERN stock have gained 35.3% over the past three months, outperforming the transportation-truck industry’s 9.8% surge, as well as that of other industry players, Old Dominion Freight Line, Inc. (ODFL - Free Report) and Knight-Swift Transportation Holdings Inc. (KNX - Free Report) within the same time frame.
WERN Stock’s Three-Month Price Comparison Image Source: Zacks Investment Research
What Do Earnings Estimates Say for WERN?The positive sentiment surrounding WERN stock is evident from the fact that the Zacks Consensus Estimate for the third quarter of 2026 and the fourth quarter of 2026 earnings has been revised upward in the past 90 days. The consensus mark for 2026 and 2027 earnings has also been projected northward in the past 90 days.
The favorable estimate revisions indicate brokers’ confidence in the stock.
Image Source: Zacks Investment Research
Time to Buy WERN StockIt is understood that WERN stock is currently attractively valued. Consistent shareholder-friendly initiatives boost investor confidence and positively impact the bottom line. WERN has a consistent track record of paying out dividends since 1987. A solid balance sheet allows the company to continue paying dividends and buying back shares, reflecting its pro-shareholder stance. Apart from being shareholder-friendly, Werner's top line continues to benefit from strength across both its Truckload Transportation Services segment and Logistics segment.
We believe that the positives surrounding the stock (as highlighted throughout the write-up) outweigh the concerns regarding rising expenses related to salaries, wages, and benefits, equipment, maintenance, fuel, and other expenses and driver shortage issues. We, therefore, suggest investors add Werner stock to their portfolios for healthy returns. The company’s Zacks Rank #1 (Strong Buy) further supports our thesis. You can see the complete list of today’s Zacks #1 Rank stocks here.
Host Hotels zvýšil výhled růstu srovnatelného hotelového RevPAR na 3–4,5 % a celkového RevPAR na 3,5–5 % po silném 1. čtvrtletí 2026. Akcie HST za tři měsíce vzrostly o 18,8 %.
Key Takeaways HST shares gained 18.8% in three months, supported by demand in key U.S. and Sunbelt markets.HST raised 2026 comparable hotel RevPAR and total RevPAR growth guidance after a strong first quarter.Host Hotels backs growth with capital recycling, strong liquidity and ongoing dividends and share repurchases. Shares of Host Hotels & Resorts Inc. (HST - Free Report) have gained 18.8% in the past three months compared with the industry’s growth of 2.3%.
Host Hotels, which has a portfolio of luxury and upper-upscale hotels in top U.S. markets and the Sunbelt region, is poised to benefit from the strong demand drivers in these markets.
Strong leisure demand and improving group business are expected to support the RevPAR growth through healthy occupancy trends. Also, a strategic capital-recycling program and a healthy balance sheet augur well.
Analysts seem positive on this lodging REIT, which currently carries a Zacks Rank #3 (Hold). The Zacks Consensus Estimate for its 2026 FFO per share has been revised 2 cents northward to $2.13 over the past month.
Image Source: Zacks Investment Research
Factors Behind HST’s Share Price RiseHost Hotels has a strong Sunbelt exposure and a presence in the top 21 U.S. markets. Its properties are strategically located in central business districts, near major airports and resort and conference destinations, which support both leisure and business travel demand.
In the first quarter of 2026, comparable hotel RevPAR rose 4.4% year over year, while comparable hotel total RevPAR increased 4.6%. Reflecting solid demand trends, management raised full-year 2026 comparable hotel RevPAR growth guidance to 3-4.5% and total RevPAR growth guidance to 3.5-5%. The outlook is supported by continued leisure and group travel demand, as well as incremental demand expected from major events, including the 2026 FIFA World Cup. With supply growth in its markets and chain scales remaining low, this backdrop should support continued RevPAR growth.
Host Hotels continues to sell non-strategic assets and redeploy the proceeds into higher-quality hotels and portfolio reinvestment. Per the company’s May 2026 Investor Presentation, from 2021 to 2026, it completed $2.9 billion of dispositions at a 16.2x EBITDA multiple. Its acquisitions during this period totaled $3.3 billion at a 13.3x EBITDA multiple. With the hotel transaction activity remaining relatively muted, the company’s scale and investment-grade balance sheet provide the flexibility to pursue acquisitions and continue capital recycling when valuations are favorable.
Host Hotels maintains a strong balance sheet that provides flexibility to reinvest in its portfolio. As of March 31, 2026, the company had approximately $3.4 billion of total available liquidity. Total debt was approximately $5.1 billion, with a weighted average maturity of 4.9 years and a weighted average interest rate of 4.8%. The company had no significant debt maturities in 2026. Net leverage was 2.5x on a credit facility basis, while 99% of the consolidated portfolio was unencumbered, underscoring its financial flexibility. This strong liquidity position should help Host Hotels fund its 2026 capital program while preserving financial flexibility for acquisitions and shareholder returns, including dividends and share repurchases.
Host Hotels continues to emphasize shareholder returns through dividends and repurchases. The board authorized a regular quarterly dividend of 20 cents per share and a special dividend of 72-cent per share, payable in mid-July to stockholders of record at the end of June. During the first quarter, the company repurchased 4.0 million shares for $75 million at an average price of $18.97, and it had $405 million of remaining authorization at quarter end. This supports continued capital returns to shareholders.
With the factors mentioned above, the positive trend in the stock is expected to continue in the near term.
Risks Likely to Affect HST’s Positive TrendMacroeconomic uncertainty and a cautious approach by many businesses are likely to hurt demand for its properties in the near term. The competitive landscape and elevated interest expenses are other concerns.
Stocks to ConsiderSome better-ranked stocks from the broader REIT sector are Cousins Properties (CUZ - Free Report) and Welltower (WELL - Free Report) , each carrying a Zacks Rank of #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for CUZ’s 2026 FFO per share is pegged at $2.95, which indicates year-over-year growth of 3.87%.
The Zacks Consensus Estimate for WELL’s full-year FFO per share is pinned at $6.32, which calls for an increase of 19.47% from the year-ago period’s level.
Note: Anything related to earnings presented in this write-up represents FFO, a widely used metric to gauge the performance of REITs.
Bank of America zvýšila cílovou cenu SharkNinja na 165 USD z 145 USD a potvrdila doporučení Buy po silnějších domácích tržbách. Prodeje v USA podle Nielsen vzrostly o 17 % a 86,2 % pro týdny končící 20. a 27. června; na souhrnné bázi pak meziročně o 51,5 %.
SharkNinja Inc (NYSE:SN.) received a higher price target from Bank of America, which raised its price objective to $165 from $145 and reiterated its 'Buy' rating after stronger domestic sales trends lifted its second quarter sell-through estimates.
Shares of SharkNinja currently trade at about $150, up almost 35% so far this year.
The firm wrote that Nielsen point-of-sale data showed domestic SharkNinja product sell-through increased 17% and 86.2% for the weeks ending June 20 and June 27, respectively. On a combined basis, sell-through rose 51.5% year over year, supported by the timing of Amazon's Prime Day and upward revisions to prior weeks.
Bank of America wrote that SharkNinja's second quarter 2026 domestic sell-through is now tracking at 25.7%, up from 18.4% two weeks earlier and well ahead of estimated industry growth of 2.6%.
Based on the stronger sales performance, the firm’s improved price target was reached by applying an approximately 23x price-to-earnings multiple to the its 2027 earnings estimate, compared with 20x previously.
The analysts also highlighted SharkNinja's direct-to-consumer business, with the firm estimating those channels contribute 200 to 300 basis points to overall sales growth.
Bank of America wrote that several SharkNinja products have recently gained traction on TikTok, aided by summer demand and influencer engagement. The analysts pointed to strong online interest in products including the Ninja SLUSHi, ChillPill, and Ninja Frost Vault Cooler, with multiple videos generating millions of views in recent weeks.
The firm also highlighted top-selling products on SharkNinja's TikTok Shop, including the Ninja Single-Serve Specialty Coffee Maker, Ninja Belgian Waffle Maker Pro, Ninja SLUSHi Professional Frozen Drink Maker, and Shark HydroDuo and Shark StainStriker cleaning products.
PacBio těží z vývoje produktů a zisku nad odhady v 1. čtvrtletí, ale slabší výzkumné financování dál brzdí poptávku po systémech Revio a Vega. Firma nečeká výrazné zlepšení výzkumného financování do roku 2026.
Key Takeaways PacBio gains from product development and a Q1 earnings beat despite funding challenges.PACB's SPRQ-Nx chemistry boosts yields and targets sub-$300 genome sequencing at scale.PacBio sees research funding uncertainty weighing on Revio and Vega demand through 2026. Pacific Biosciences of California, Inc. (PACB - Free Report) , popularly known as PacBio, has been gaining from its continued product development. The optimism, led by strong first-quarter results, is expected to contribute further. However, concerns about funding headwinds persist.
In the year-to-date period, this Zacks Rank #2 (Buy) company’s shares have lost 11.2% compared with the 12.4% decline of the industry. The S&P 500 Composite has improved 9.4% in the said time frame.
The renowned global provider of sequencing systems has a market capitalization of $521.8 million. The company projects 22.6% growth for 2026 and expects to maintain its strong performance in the future. PacBio’s earnings surpassed the Zacks Consensus Estimate in all the trailing four quarters, delivering an average surprise of 29.8%.
Image Source: Zacks Investment Research
Factors Favoring PACB’s GrowthSequencing Technologies Strengthen Market Leadership: PacBio differentiates itself in the genomics industry through its proprietary HiFi long-read sequencing, based on Single-Molecule Real-Time (SMRT) technology. This technology enables the high-accuracy, real-time detection of complex genomic structures, such as structural variations, haplotypes and epigenetic modifications.
Per a report by Data Bridge Market Research, the global SMRT market size was valued at $2.88 billion in 2024 and is projected to reach $4.36 billion by 2032, at a CAGR of 5.3%. Additionally, PacBio has expanded its offerings by integrating Sequencing by Binding chemistry with the launch of its Onso system in 2022, a short-read platform delivering ≥90% of bases at Q40+ accuracy, 15 times more precise than traditional sequencing methods. By providing both long-read and short-read technologies, PacBio uniquely serves diverse research and clinical applications while driving down costs and enhancing variant detection.
Robust Product Portfolio Driving Growth: PacBio continues to strengthen its competitive position through innovation in its HiFi sequencing platform. The company's SPRQ-Nx chemistry is gaining traction, delivering higher sequencing yields and enabling human whole-genome sequencing costs below $300 at scale through reusable SMRT Cells. Management plans to extend the technology to the Vega platform later this year, enhancing throughput and workflow efficiency.
PacBio is also advancing its next-generation ultra-high-throughput sequencing platform to target large-scale clinical and population genomics opportunities. Additionally, its collaboration with Basecamp Research to sequence roughly 100,000 metagenomic samples highlights the expanding role of HiFi sequencing in AI-driven biological research and underscores the technology's growing adoption across emerging applications.
Strong Q1 Results: PacBio exited the first quarter of 2026 with mixed results, wherein earnings beat the Zacks Consensus Estimate while revenues missed the same. Stable top-line performance, despite softer instrument sales, reflected continued strength in consumables demand and improving utilization trends across the installed base.
Growth in consumables revenues, expansion across the EMEA region and disciplined expense management were encouraging. The company also reported a significantly narrower operating loss year over year, supported by lower operating expenses and continued restructuring benefits.
A Factor That May Offset PACB’s GainsFunding Headwinds Continue to Weigh on Instrument Demand: PacBio continues to face funding-related headwinds that are weighing on instrument demand, particularly across academic and government research markets. Uncertainty around grant funding and cautious capital spending have pressured purchases of both Revio and Vega systems, with Vega being more exposed to academic budget constraints.
While the company is seeing growing interest from clinical and commercial customers, management does not anticipate a meaningful recovery in research funding through 2026 and recently lowered the high end of its annual revenue outlook due in part to weaker instrument demand. Although the upcoming commercial launch of SPRQ-Nx chemistry could improve the attractiveness of PacBio’s sequencing platforms by lowering costs and boosting throughput, near-term instrument growth is expected to remain dependent on expanding clinical adoption rather than a broad recovery in research spending.
Estimate TrendPacBio has been witnessing a stable estimate revision trend for 2026. Over the past 30 days, the Zacks Consensus Estimate for its adjusted loss per share has remained stable at 41 cents.
The Zacks Consensus Estimate for 2026 revenues is pegged at $165.8 million, indicating a 3.6% increase from the year-ago reported numbers.
Other Key PicksSome other top-ranked stocks from the broader medical space are Globus Medical (GMED - Free Report) , West Pharmaceutical (WST - Free Report) and Intuitive Surgical (ISRG - Free Report) .
Globus Medical, currently carrying a Zacks Rank #2, reported a first-quarter 2026 adjusted earnings per share (EPS) of $1.12 per share, which surpassed the Zacks Consensus Estimate by 22.1%. Revenues of $759.9 million beat the Zacks Consensus Estimate by 4.0%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
GMED has an estimated long-term earnings growth rate of 10.2% compared with the industry’s 12.6% growth. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 26.3%.
West Pharmaceutical, currently carrying a Zacks Rank #2, reported first-quarter 2026 EPS of $2.13, which beat the Zacks Consensus Estimate by 26.8%. Revenues of $844.9 million surpassed the Zacks Consensus Estimate by 8.5%.
WST has an estimated long-term earnings growth rate of 13.9% compared with the industry’s 9.5% growth. The company’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 19.4%.
Intuitive Surgical, carrying a Zacks Rank #2 at present, reported first-quarter 2026 adjusted EPS of $2.50, which beat the Zacks Consensus Estimate by 20.2%. Revenues of $2.77 billion surpassed the Zacks Consensus Estimate by 6.2%.
ISRG has a long-term estimated growth rate of 14.6% compared with the industry’s 12.6% growth. The company’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.8%.
Reddit posiluje bezpečnost AI: zavádí ověřování botů, detekci spamu a soukromé ověřování lidí, aby chránil autentické diskuse. Cílí na 100 milionů denních uživatelů v USA.
Key Takeaways Reddit is expanding AI safety with bot verification, spam detection and privacy-focused human checks. RDDT aims to protect authentic conversations through stronger moderation, transparency and safety tools. Reddit targets 100 million daily U.S. users through product, onboarding and community improvements. Reddit (RDDT - Free Report) is benefiting from its accelerated focus on AI safety and user trust, which has become a cornerstone of its growth strategy in 2026. The company’s leadership recognizes that authentic human conversation is a scarce and increasingly valuable asset in the digital age.
With more than 25 billion posts and comments and nearly 500 million weekly users, Reddit’s platform is uniquely positioned to provide real human perspectives, an essential resource for both AI model training and genuine user engagement. To protect the integrity of this large collection of human-generated content, Reddit has increased its AI safety efforts by advancing bot verification, increasing transparency around automated accounts, and adopting secure authentication technologies such as Passkeys.
Further expanding its AI safety initiatives, Reddit has outlined new measures to preserve authentic human conversations as AI-generated content becomes more common online. The company is expanding AI-powered detection systems to identify spam, fake engagement, and coordinated manipulation while strengthening human oversight and moderator tools.
Reddit is also introducing privacy-focused human verification methods to distinguish real users from bots without compromising anonymity. RDDT will continue investing in safety technologies, transparency, and community-driven moderation to ensure discussions remain trustworthy. These efforts are designed to protect Reddit’s unique value as a platform built on genuine human experiences and conversations in the AI era.
Reddit’s commitment to AI safety and user trust is expected to be a key driver of both user growth and monetization. The company’s goal to reach 100 million daily U.S. users is underpinned by ongoing improvements in product quality, onboarding and community support.
RDDT Faces Stiff CompetitionRDDT is facing stiff competition from competitors like Meta Platforms (META - Free Report) and Snap (SNAP - Free Report) . Both Meta Platforms and Snap are also expanding their footprint in the AI space.
Meta Platform is benefiting from its accelerating growth into artificial intelligence (AI), which is driving significant top-line growth. Meta Platform’s release of the Muse family of models and the upgraded Meta AI assistant has positioned the company as a leader in personal superintelligence, with billions of users now accessing these AI-powered features. This surge in AI-driven engagement is translating directly into top-line growth, as evidenced by a 33% year-over-year increase in total revenues to $56.3 billion for the quarter.
Snap has introduced a suite of AI-powered advertising tools to help brands create, optimize and personalize campaigns on Snapchat. New features include AI-assisted campaign setup, image-to-video generation, creative enhancement, conversational AI Sponsored Snaps and creator marketplace automation, aimed at improving engagement, commerce and advertising performance across its platform.
RDDT’s Share Price Performance, Valuation, and EstimatesRDDT shares have plunged 12.6% year to date, underperforming the broader Zacks Computer & Technology sector’s 14.7% increase and the Internet - Software industry’s 11.2% decline.
RDDT Stock Performance
Image Source: Zacks Investment Research
RDDT shares are overvalued, with a forward 12-month Price/Sales of 10.19X compared with the Computer & Technology sector’s 6.88X. RDDT has a Value Score of F.
RDDT's Valuation
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for 2026 earnings is pegged at $4.83 per share, which has been unchanged over the past 30 days. This suggests 84.35% year-over-year growth.
Reddit currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Bank of America vidí Figma jako vítěze AI, protože generativní umělá inteligence podle ní zvyšuje poptávku po spolupráci při vývoji produktů. Akcie Figma byly v době zveřejnění o 9,49 % výše.
The brokerage said Figma’s stock has fallen about 85% from its 52-week high as investors worried that generative AI would reduce the need for design software.
However, Bank of America believes AI is expanding demand for collaborative product development and creating new monetization opportunities through Figma’s hybrid seat-based and usage-based pricing model.
The firm values Figma at 8 times estimated 2027 enterprise value-to-sales, above the peer average of about 5.9 times, citing the company’s stronger growth outlook and growing role in AI-powered software development.
AI Seen Driving AdoptionBank of America said AI is increasing the number of people creating digital products while also making workflows more complex. That, in turn, should increase demand for a centralized platform where designers, developers and product teams can collaborate.
The analysts pointed to early evidence that AI is already contributing to revenue growth. During the first quarter of 2026, 75% of enterprise customers that exceeded their AI credit limits purchased additional credits, while more than 95% remained active on the platform. Enterprise customers generating more than $100,000 in annual recurring revenue increased 48% year over year, while net dollar retention reached 139%.
Growth OutlookBank of America projects revenue growth of 35.6% in 2026 and 23% in 2027, compared with peer averages of 19.3% and 15.7%, respectively. The brokerage expects AI investments to pressure margins in the near term but forecasts operating margin expansion from 9.2% in 2026 to 13.8% by 2028, alongside improving free cash flow margins.
The analysts also highlighted continued enterprise adoption as a key growth driver. They estimate the number of customers generating more than $100,000 in annual recurring revenue will grow 26.2% in 2026 before moderating to more than 22% annually through 2028.
Risks RemainDespite its bullish stance, Bank of America said risks include slower-than-expected AI adoption, increasing competition from AI-native design tools and weaker monetization of AI features. Even so, the firm believes those concerns are already reflected in Figma’s valuation and views the company as an AI beneficiary rather than an AI casualty.
FIG Stock Price Activity: Figma shares were up 9.49% at $23.08 at the time of publication on Tuesday, according to Benzinga Pro data.
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Image Credits:Figma Figma is trying to become more than a design platform by adding more AI and bringing the coding and prototyping layer closer to its canvas. Toward that end, it has acquired the team behind the vibe-coding and AI agent platform Bud (formerly Orchids).
“Figma is one of, if not the, defining product companies of our time to capitalize on this. It’s where ideas start, iterate, and come to life, and a natural home for this exciting new era of work,” Bud’s CEO Kevin Lu posted on X.
The Y Combinator-backed startup began as a vibe-coding platform letting users spin up apps for mobile, web, Slack, browser, and more. It later rebranded as Bud, an agent platform that can access various services, browse the web, and write code to automate tasks.
Under the deal, the startup will shut down both Bud and Orchids by July 18, requiring users to migrate their projects by then.
Earlier this year, citing a security researcher, the BBC reported that apps created on Orchids were susceptible to cyberattacks.
Figma didn’t specify how it aims to use this team, but recent product launches hint that the public company wants to give teams more tools for building and prototyping apps, not just ideating over static concepts. Last year, it released Figma Make for creating web apps. This year, it integrated with tools like Codex and Claude Code, and rolled out its own agents.
SailPoint v 1. čtvrtletí zvýšil celkové ARR o 26 % na 1,163 mld. USD, tažené růstem tržeb z SaaS o 36 % na 781 mil. USD. AI funkce používá asi 10 % zákazníků.
Key Takeaways SailPoint's growth is increasingly SaaS-led as total ARR rose 26% to $1.163B in the fiscal first quarter.Non-human identities drove 40% of identity growth, while AI capabilities reached about 10% of customers.SailPoint still has about $350M of on-premise ARR to migrate, with only 10% expected in fiscal 2027. SailPoint (SAIL - Free Report) is trying to broaden its role in enterprise security as identity expands beyond employees to machines, contractors and AI agents. That shift gives SailPoint a larger opportunity, but it also makes execution more complicated. SaaS adoption, AI-related demand and on-premise migrations are all moving together, creating a growth story with timing risk.
SailPoint’s platform is built around identity governance, with Identity Security Cloud and IdentityIQ serving as its core offerings. The company helps enterprises manage lifecycle events, certify access, enforce least-privilege controls and analyze risk across complex systems.
The strategic role is getting broader. SailPoint now frames identity as a control plane for human and non-human identities, including machine identities and AI agents. That matters for large enterprises and government accounts that need auditable access controls across cloud, legacy and custom applications.
SAIL Growth is Being Led by SaaS ARRSailPoint’s growth engine is increasingly SaaS-driven. Total annual recurring revenue reached $1.163 billion in the first quarter of fiscal 2027, up 26% year over year, while SaaS annual recurring revenue rose 36% to $781 million.
SaaS represented 92% of net new annual recurring revenue in the quarter, compared with 69% a year earlier. Dollar-based net retention held at 113%, showing that existing customers continue to expand usage and add capabilities.
For second-quarter fiscal 2027, SailPoint expects revenues between $308 million and $312 million, indicating year-over-year growth of 17-18%. Adjusted earnings are expected to be between 7 cents and 8 cents per share for the second quarter of fiscal 2027.
SailPoint AI Push is Becoming More TangibleAI is no longer just a product narrative for SailPoint. Non-human identities accounted for 40% of identity growth in the first quarter of fiscal 2027 and represented 14% of all identities managed in the company’s cloud offering. Management said about 10% of customers had adopted AI capabilities. Agentic Fabric and related launches are aimed at discovering AI agents, mapping ownership, enforcing authorization, securing prompts and monitoring behavior. Okta (OKTA - Free Report) , Cisco Systems (CSCO - Free Report) and Microsoft (MSFT - Free Report) are other identity-focused companies investors may watch in this context.
Microsoft is SailPoint’s most significant competitor through its Microsoft Entra portfolio, which includes Entra ID, Identity Governance, Privileged Identity Management (PIM) and Conditional Access. Microsoft’s biggest advantage is its massive installed base of Microsoft 365 and Azure customers, allowing it to bundle identity governance with productivity, cloud and security offerings at attractive pricing.
Meanwhile, following the acquisition of Splunk and continued investment in cybersecurity, Cisco has strengthened its identity-focused security capabilities through Cisco Duo and its broader Zero Trust platform. Duo provides multi-factor authentication, device trust, adaptive access and identity verification, while Cisco integrates identity signals with networking and security operations.
Okta’s outlook is supported by steady demand for identity security, an expanding installed base, and rising attach of newer products such as Identity Governance, Privileged Access, and posture and threat capabilities. Management’s agent-focused roadmap and broad partner ecosystem keep Okta relevant as enterprises secure non-human identities and deploy AI workflows across multiple platforms.
SailPoint shares have dropped 18% year to date, outperforming Microsoft’s fall of 18.7%, while Okta and Cisco shares have returned 74.1% and 46.7%, respectively.
SAIL Stock’s Price Performance
Image Source: Zacks Investment Research
SAIL Migration Opportunity Still Has FrictionThe migration opportunity remains a major swing factor. SailPoint still has about $350 million of on-premise annual recurring revenue available for migration, and management has pointed to a typical 2-3 times uplift when customers move to SaaS and add capabilities.
The challenge is timing. These migrations can be complex, especially for large enterprises with legacy infrastructure and regulatory requirements. SailPoint expects only about 10% of its on-premise base to migrate in fiscal 2027, leaving a long runway but also making execution discipline important.
SailPoint Margins and Cash Flow Add SupportGrowth is not coming at the expense of operating discipline. Adjusted operating margin improved to 13.5% in the first quarter of fiscal 2027 from 10.2% a year earlier.
Cash generation also improved the setup. SailPoint delivered $38 million in operating cash flow and $33 million in free cash flow during the quarter. Management also raised fiscal 2027 targets for annual recurring revenue, revenues and adjusted operating margin.
ConclusionThe bottom line is that SailPoint has a credible growth story tied to SaaS adoption, AI identity governance and enterprise migrations. Still, the pace of on-premise conversions and the revenue-recognition effects of the SaaS shift keep the near-term setup balanced.
SAIL currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
JPMorgan čeká, že tržby SpaceX porostou o 91 % ročně do roku 2030, ale hlavním motorem má být AI infrastruktura, ne jen více startů raket. Banka vidí tržby 470 miliard USD v roce 2030.
The real headline may be the bank’s expectation that the company can grow revenue at a staggering 91% annual rate through 2030—a forecast that, according to JPMorgan, has surprisingly little to do with selling more rocket launches.
Instead, analyst Doug Anmuth argues launches are simply the foundation for a much bigger business.
The AI Story Hidden Behind the RocketsFor years, investors have viewed SpaceX primarily as a launch company powered by Falcon rockets and Starlink satellites.
JPMorgan believes that narrative is already becoming outdated.
Anmuth says “launch is SpaceX’s core competitive advantage that enables every other part of the business,” with rapid Starship reusability laying the groundwork for an AI infrastructure platform rather than simply a larger launch business.
By 2031, JPMorgan expects Starship launches to ramp from only a handful this year to roughly 5,000 annually, enabling SpaceX to deploy 75 gigawatts of orbital compute as it pursues an addressable market exceeding $28 trillion.
From Connectivity to AIThat shift fundamentally changes SpaceX’s financial profile.
JPMorgan projects revenue climbing from $19 billion in 2025 to $470 billion by 2030, while operating margins improve from negative 14% to roughly 50% over the same period. The driver isn’t simply more launch activity, but what the report describes as a business mix shifting from “Connectivity to AI, first terrestrial, and then orbital.”
Anmuth argues that transition justifies valuing SpaceX more like a next-generation AI infrastructure company than a traditional aerospace business.
Why Launch Still MattersIronically, the bullish AI thesis begins with rockets.
SpaceX has completed roughly 670 orbital launches with a 99%+ mission success rate and has launched more than 80% of all mass sent to orbit since 2023, according to JPMorgan. Those capabilities—and Starship’s rapid reusability—give the company a structural advantage that competitors cannot easily replicate.
That launch leadership, combined with what Anmuth calls SpaceX’s “extreme vertical integration,” enables the company to build not only rockets but also satellites, AI infrastructure and, eventually, orbital data centers faster and more cheaply than rivals.
For investors, that may be the biggest takeaway from JPMorgan’s initiation.
The firm’s $225 price target implies meaningful upside. But the more important bet is that SpaceX’s next decade won’t be defined by how many rockets it launches—it will be defined by what those rockets make possible.
Image via Shutterstock
Market News and Data brought to you by Benzinga APIs
I keep hitting the buy button on Apple (NASDAQ:AAPL | AAPL Price Prediction), and the July 30 earnings report is not slowing me down. Every payday, I add a few more shares. The reasons are boring, repeatable, and they stack in my favor over years, which is the profile I want in a core holding heading into retirement. Here is what keeps pulling me back.
A cash machine that pays me to wait Apple generated $111.48 billion in operating cash flow in FY25 and returned $90.71 billion to shareholders through buybacks that same year. In April, the board authorized another $100 billion repurchase program and raised the quarterly dividend 4% to $0.27. Total capital returned since the program began now exceeds $1 trillion. The 0.34% yield looks small in isolation, but paired with ROE of 171.4% and ROIC of 53.3%, I am fine with management compounding capital inside the business instead of mailing it out.
The Services engine keeps widening the moat Q2 FY26 revenue reached $111.18 billion, up 16.6% year over year, with iPhone at $56.99 billion and Services at an all-time record $30.98 billion. Services gross margin ran at 76.7% on a base of over 2.5 billion active devices. That is a high-margin annuity riding on hardware customers already own. Tim Cook described Apple Intelligence as “woven into the core of our platforms”, and MacBook Neo demand is running so hot he flagged the company was “supply constrained”. Greater China grew 28% in the March quarter. Management guided June-quarter revenue growth of 14% to 17% with gross margin of 47.5% to 48.5%. That is what the July 30 report will confirm.
An earnings track record I trust Apple has delivered nine consecutive beats, with the last quarter posting an EPS of $2.01 against a $1.94 estimate. In the 30 days after that May report, shares rose 10.75%, outpacing SPY by 6.09 percentage points. Over the past year the stock is up 45.86%, and over ten years it is up 1,313.91% on a split-adjusted basis. That is the kind of compounding I plan around.
The risk I actually respect China exposure and the supply chain keep me disciplined. Greater China revenue was $20.50 billion last quarter, and Cook warned that “significantly higher memory costs” will pressure the June quarter. Add the CEO handoff to John Ternus effective September 1, 2026 and the execution bar is real. My response: those memory costs are already baked into the 47.5% to 48.5% margin guide, and Ternus is a 25-year Apple veteran inheriting a roadmap Cook publicly called “incredible”.
Why the buy button stays active At a P/E of 40 on a business printing 26.9% net margins at a $4.53 trillion market cap, Apple looks pricey on the screen and reasonable on the cash it will send my account over the next decade. I plan to keep buying through July 30, and the quarter after that, and the one after that.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Apple didn't make the cut. Grab the names FREE today.
UBS uvedla, že růst tržeb App Store ve čtvrtletí končícím v červnu zpomalil na zhruba 3 % meziročně, v USA tržby klesly asi o 6 %. Analytici to spojují i s ochlazováním aktivity kolem generativní AI.
Apple Inc (NASDAQ:AAPL, XETRA:APC)'s App Store revenue growth slowed in the June 2026 quarter, according to an analysis by UBS, which tracked third-party App Store data from Sensor Tower.
UBS analysts wrote that the App Store recorded approximately 3% year-over-year growth on a reported basis during the quarter, while growth was around 2% on a foreign exchange-neutral basis. The firm noted that growth slowed by roughly 440 basis points compared with the prior quarter, despite only a slightly more challenging comparison period.
The US market was a key source of weakness, with App Store revenue declining approximately 6% year-over-year in the quarter, UBS wrote. In other regions, the App Store grew about 9% year-over-year on a reported basis.
UBS wrote that Apple’s September 2026 quarter will face an easier comparison period, with the year-over-year growth benchmark expected to be around 10%, approximately 270 basis points lower than the June quarter comparison.
The analysts maintained their June-quarter Services revenue estimate, forecasting growth of about 14.3% year-over-year, compared with consensus expectations of roughly 14.5%.
UBS wrote that the estimate remains unchanged despite potential downside risks from slower App Store growth, noting that Apple’s Services segment continued to show strength in the March 2026 quarter, when Services revenue increased about 16.3% despite App Store growth of roughly 8%.
UBS also flagged slowing growth in generative artificial intelligence-related activity, which it views as a contributor to App Store growth. The firm wrote that AI-related growth may be moderating due to tougher comparisons and increasing market saturation.
For valuation, UBS maintained a price target of $296 for Apple shares, based on a valuation multiple of 30 times its calendar 2027 earnings-per-share estimate of $9.86. UBS wrote that the valuation reflects balanced expectations for solid demand alongside uncertainty surrounding Apple’s artificial intelligence strategy.
Shares of Apple were little changed at $313 on Tuesday afternoon.
Meta Platforms v úterý rostla po zlepšení doporučení analytiků; Erste Group zvýšila doporučení na Buy a BNP Paribas potvrdila Outperform před výsledky za druhé čtvrtletí.
The gains came amid improving analyst sentiment and growing investor optimism over Meta’s long-term artificial intelligence monetization strategy.
Erste Group upgraded the stock to Buy from Hold, while BNP Paribas reiterated its Outperform rating ahead of second-quarter earnings.
BNP Paribas said Meta remains well-positioned to sustain revenue growth despite rising AI infrastructure spending and sees a potential future cloud offering as an additional long-term growth opportunity.
Analyst Outlook Ahead Of EarningsBNP Paribas reiterated its Outperform rating and $955 price forecast on Meta ahead of the company’s expected earnings release in the last week of July.
Senior analyst Nick Jones said investors are likely to focus on Meta’s capital spending plans, AI product development, a potential cloud offering and subscription adoption trends.
The analyst expects second-quarter revenue growth to slow from prior quarters because of temporary factors but believes the company can maintain long-term top-line momentum.
Revenue And Earnings ExpectationsBNP Paribas said Meta’s valuation suggests investors remain cautious about earnings growth, the scale of AI investments, returns on those investments, competition in artificial intelligence and the broader macroeconomic environment.
Jones said investors are expecting second-quarter revenue growth of 27% to 29% year over year, compared with the consensus estimate of 27%. He also expects GAAP diluted earnings per share above $7.40, versus the Street consensus of $7.19.
For the third quarter, BNP Paribas believes investors are looking for revenue guidance of $62 billion to $64 billion, compared with the consensus estimate of $63.2 billion.
AI Spending Remains In FocusThe analyst also expects Meta to raise its 2026 capital expenditure outlook by at least $10 billion from its current $125 billion to $145 billion range as higher component costs continue to inflate AI infrastructure spending.
Despite slowing user growth as Meta’s platforms approach saturation, BNP Paribas said engagement remains a key strength. The firm estimates Meta accounts for more than 40% of time spent across major social media platforms, nearly double that of its next-largest competitor. That, it said, should support continued growth in revenue per daily active person.
BNP Paribas expects Meta to fund its elevated AI investments through stronger monetization of AI features, advertising market share gains, subscription revenue and the optionality of a future cloud offering.
Meta Platforms Technical AnalysisMeta is trading about 5.4% above its 20-day simple moving average and slightly above its 50-day moving average. However, the stock remains below both its 100-day and 200-day moving averages, suggesting the longer-term trend has yet to turn positive.
Momentum indicators have improved. The moving average convergence divergence (MACD) remains above its signal line, indicating selling pressure has eased.
Even so, the broader trend remains cautious. The 20-day moving average is still below the 50-day average, while the 50-day average remains below the 200-day average following a death cross that formed in December 2025.
Technical analysts are watching resistance near $643, close to the 200-day moving average. Initial support sits around $595 near the 50-day moving average.
Earnings Remain The Next Major CatalystAttention is now shifting to Meta’s expected second-quarter earnings report, estimated for July 29, 2026, which could shape the stock’s next move.
Wall Street expects earnings per share of $7.18, up from $7.14 a year earlier. Revenue is projected to increase to $60.22 billion from $47.52 billion.
The stock trades at roughly 21.8 times earnings and carries a consensus Buy rating. The average analyst price forecast stands at $826.88. Recent analyst actions include:
Erste Group upgraded the stock to Buy on Tuesday. Wells Fargo maintained an Overweight rating and raised its price forecast to $767 on July 2. RBC Capital Markets reiterated its Outperform rating with an $810 price forecast on June 1. Meta Platforms Price ActionMETA Stock Price Activity: Meta Platforms shares were up 1.42% at $608.83 at the time of publication on Tuesday, according to Benzinga Pro data.
Image via Shutterstock
Market News and Data brought to you by Benzinga APIs
Meta představila nový model Muse Image pro generování obrázků a chce jím přilákat tvůrce i inzerenty. Model bude zdarma v aplikaci a na webu Meta AI, ve WhatsApp přímých zprávách a v Instagram Stories, ale pokročilé funkce budou součástí placených předplatných. Později v roce má být dostupný také na Facebooku a Messengeru i v dalších částech Instagramu a WhatsApp.
Meta on Tuesday released Muse Image, a new artificial intelligence model for creating images as the company seeks to attract creators and advertisers to its offerings.
Originally codenamed Mango, the AI technology marks the second major release from Meta Superintelligence Labs led by Alexandr Wang, who oversaw the April unveiling of the Muse Spark large language model that succeeded the company's previous Llama family of models.
Muse Image will be available for consumers to access for free via the Meta AI app and site, WhatsApp direct messages and Instagram Stories. Power users and creators must sign up for one of Meta's new monthly subscription plans that debuted in May to create many AI-generated images and access certain features. If users hit their free limit, they can purchase a Meta One subscription or wait until their limit resets, the company said.
Muse Image will also power advertiser-specific, image-generation tools as part of Meta's AI-powered Advantage Plus service that lets brands more easily develop ad creative for their marketing campaigns and automate certain tasks. Meta said it's been working with businesses and advertisers as part of debuting Muse Image.
"Muse Image brings native reasoning to the creative process to adjust elements, swap styles, and create variations based on the advertiser's creative, resulting in high-quality, on-brand ad variations with fewer iterations," the company said in a blog post for businesses. "In the coming weeks, advertisers and agencies can expect to see image variants powered by Muse Image."
Read more CNBC tech newsChinese lidar maker with Nvidia ties accused of being cyber risk for U.S.China's Alibaba bans Anthropic AI for employees after 'distillation attack' accusationSpaceX President Gwynne Shotwell to donate stock to Trump AccountsMicrosoft cuts 4,800 jobs, as Xbox unit downsizes and plans to spin off four gaming studiosThe new image-generation model and efforts to monetize it show how Meta is trying to expand from its core business of online advertising and generate new revenue sources tied to its hefty spending on AI-related infrastructure.
OpenAI and Alphabet got a head start over Meta in offering similar image-generation models, with Google's Nano Banana becoming a hit with consumers when it was released last fall.
Meta also revealed internal benchmark tests showing Muse Image trailing OpenAI's latest GPT Image 2 model but beating the Nano Banana 2 model in tasks like editing both single and multiple images.
The social media giant has previously used third-party AI models like Midjourney and Black Forest Labs to power various image and video generation features within its Meta AI app and site. The company said it plans to use its new AI model to reduce reliance on similar third-party technologies.
Meta also plans to release an AI video generation model dubbed Muse Video at a later date, adding in a technical blog that it "offers competitive performance in prompt adherence, visual fidelity, and temporal consistency."
Muse Image will be available on Facebook and Messenger as well as more areas within the Instagram and WhatsApp services later in the year.
Nvidia je jen necelých 6 % pod hranicí 5 bilionů USD, když po pondělním uzavření měla tržní hodnotu asi 4,74 bilionu USD. V prvním fiskálním čtvrtletí jí tržby meziročně vzrostly o 85 % na rekordních 81,6 miliardy USD.
Only one company in history has ever been worth $5 trillion: Nvidia (NVDA +0.55%) itself. The chipmaker first crossed the mark last October, then slipped back below it. After closing Monday at about $195.55 per share, the chipmaker carried a market value of roughly $4.74 trillion. That leaves it less than 6% below a milestone no other business has ever touched.
So how close is Nvidia, exactly, and what would it take to get there? The math is simple, and the underlying business is firing on all cylinders.
Image source: Getty Images.
The number that gets it there With about 24.2 billion shares outstanding, Nvidia crosses $5 trillion at a share price of roughly $206. From Monday's close near $195.55, that's a gain of a little more than $10 per share, or about 5.5%. Put another way, Nvidia needs to add about $260 billion in market value. That is a rounding error for a company this size, though it still exceeds the entire market value of most companies in the S&P 500.
With that said, shares are down slightly on Tuesday, so the stock will need to add a bit more than that, but the point remains: it's extremely close.
For a stock that has climbed more than 350% over the past three years on the back of the AI boom, a move that small is nothing. Nvidia has gained that much in a single day more than once. So the $5 trillion mark is less a distant summit than a step the stock could clear on any morning of good news.
What could close the gap, or widen it The case for Nvidia getting there soon rests on the same thing that got it here: extraordinary demand for its chips. In its fiscal first quarter (the period ended April 26, 2026), revenue rose 85% year over year to a record $81.6 billion. Data center revenue climbed 92% to $75.2 billion. Management then guided for about $91 billion in revenue this quarter, another sharp step up.
"The buildout of AI factories -- the largest infrastructure expansion in human history -- is accelerating at extraordinary speed," said Nvidia CEO Jensen Huang in the company's fiscal first-quarter earnings release. As long as that spending holds, the earnings power behind the stock keeps growing.
But the gap can widen just as easily, and it's widening today. Case in point: Tuesday morning's sell-off, part of a broader memory-led chip sell-off after Samsung's preliminary record quarterly profit forecast, which still wasn't enough for Wall Street, stoked fresh worries about how long the AI boom can last. That's the near-term headwind. Sentiment toward the whole sector has turned jumpy, and Nvidia rarely trades apart from it.
Meanwhile, the longer-term risks are familiar ones. Nvidia's biggest customers, including Amazon and Alphabet, are designing their own chips to lean less on it, which could soften Nvidia's pricing power over time. And the semiconductor industry has always moved in cycles, so today's demand surge probably won't run this hot forever.
It's also worth putting the company's sheer size in perspective. At about $4.7 trillion, Nvidia is already worth more than the entire annual output of most of the world's economies, and the last leg to $5 trillion alone would add about the market value of a large-cap company in a single move. That scale is a reminder of how much optimism is already reflected in the price.
Today's Change
(
0.55
%) $
1.08
Current Price
$
196.63
What the milestone actually means At about 30 times trailing earnings and less than 20 times forward earnings, Nvidia isn't priced like a stock that has run out of room. Indeed, that forward multiple is actually significantly cheaper than the broader market -- a reflection of the extraordinary trajectory of the company's underlying earnings. The real question, therefore, isn't the valuation so much as the durability of the demand behind it. If AI spending stays strong, the stock has a clear path well past $5 trillion. If today's sell-off marks the start of a genuine cooling in that spending growth, the milestone could stay out of reach for a while.
Either way, I'd treat the number itself as a curiosity, not a catalyst. What matters for investors is what happens to demand for its chips, not which side of a round number the stock happens to sit on.
Certara integruje Nvidia BioNeMo Agent Toolkit do své platformy AI pro vývoj léčiv. Silo Pharma prostřednictvím své dceřiné společnosti QwikAgents vstoupila do programu Nvidia Developer Program.
Certara is integrating Nvidia’s BioNeMo Agent Toolkit into its AI-driven drug development platform, while Silo Pharma’s subsidiary, QwikAgents, has joined the Nvidia Developer Program to strengthen its AI agent capabilities.
• Nvidia stock is gaining positive traction. Why are NVDA shares climbing?
Certara Integrates Nvidia BioNeMo Into AI Drug Development PlatformCertara said it is partnering with Nvidia to advance its open, integrated AI platform by combining its scientific software, regulatory expertise, and proprietary datasets with AI-first, agentic frameworks.
Under the collaboration, the Nvidia BioNeMo Agent Toolkit will become one of several agentic frameworks available within Certara’s platform.
The toolkit is designed to turn AI agents into autonomous life sciences researchers by providing access to Nvidia’s life sciences technology stack while complementing Certara’s biosimulation models, regulatory expertise and scientific teams.
AI Agents Target Drug Development WorkflowsAccording to Certara, specialized AI agents will analyze scientific models, datasets and domain expertise across multiple stages of drug development.
The company said these agents can support tasks such as optimizing dosing strategies using systems pharmacology models, analyzing clinical datasets, simulating patient and clinical trial scenarios, evaluating ADMET properties, assembling regulatory-ready evidence and assessing early-stage drug discovery hypotheses.
Certara added that the technology is intended to enhance the work of biosimulation experts and scientific teams by accelerating insight generation while keeping scientists at the center of decision-making.
Silo Pharma Subsidiary Joins NVIDIA Developer ProgramSeparately, Silo Pharma announced its wholly owned subsidiary, QwikAgents, has joined the Nvidia Developer Program.
The company said QwikAgents’ platform automates complex workflows using autonomous AI agents capable of reasoning, taking action and interacting with enterprise systems.
The platform also incorporates persistent memory, intelligent routing across multiple large language model providers, browser automation and secure data management to support scalable AI-driven operations.
Silo Pharma said participation in the Nvidia Developer Program will provide QwikAgents with access to Nvidia’s AI software ecosystem, development frameworks, technical training and optimization resources.
The company expects those resources to help accelerate platform enhancements as it expands AI agent capabilities for enterprise customers.
CERT/SILO Stock Price Activity: Certara shares were down 0.63% at $7.09, Silo Pharma shares were down 2.10% at $6.09 at the time of publication on Tuesday, according to Benzinga Pro data.
Image via Shutterstock/ Alexander56891
Market News and Data brought to you by Benzinga APIs
Netflix od 3. srpna přidá krátká videa od vydavatelů včetně Variety, BuzzFeed Studios, Condé Nast, Hearst Magazines, People Inc., Tastemade a dalších značek Penske Media PMX, pro předplatitele v USA, Kanadě, Británii, Irsku, Austrálii a na Novém Zélandu. Firma tím testuje zájem o levnější formáty mimo seriály a filmy.
Netflix is again experimenting with new types of content on its streaming service, as the binge model has grown dated. After expanding its service to include live content, video games, and, more recently, video podcasts, the streamer is now adding video content from publishers such as BuzzFeed Studios, Condé Nast, Hearst Magazines, People Inc., Tastemade, and various Penske Media PMX brands, like Variety, THR, Billboard, Eater, Rolling Stone, and IndieWire.
Starting August 3, Netflix will offer video content from these publishers to subscribers in the U.S., Canada, the U.K., Ireland, Australia, and New Zealand, according to Netflix and other reports released on Tuesday by Netflix’s deal partners like Variety, Billboard, THR, Rolling Stone, and others.
The new videos will vary widely in length — some run just two to three minutes, while others stretch past 20, the partners said.
For Netflix, the deal is a low-risk way to test whether its audience has an appetite for the kind of content that’s typically native to the web, such as news, lifestyle, how-tos, and other short-form formats that tend to be cheaper and faster to produce than a scripted series. If it works, Netflix could eventually build similar content in-house, though the company hasn’t said that’s the plan.
The lineup will include both licensed archival and ongoing series coming to Netflix, including BuzzFeed Celeb’s “30 Questions” and “Tasty”; Vanity Fair’s “Lie Detector Test” and “How Well Do They Know Each Other?”; AD’s “Walking Tour”; Elle’s “Where Is the Lie?”; Harper’s Bazaar’s “Burning Questions”; Billboard’s “24 Hours”; People’s “My Life in Pictures”; Travel + Leisure’s “Travel Unfiltered”; Tastemade’s “Struggle Meals”; and more.
Netflix says other publishers will be added over time.
The announcement follows a Bloomberg report this week that found that Netflix is struggling to retain fans between the first and second seasons of top shows. That trend has reportedly worried executives, though it’s largely explained by familiar culprits: high cancellation rates, long gaps between seasons, and inconsistent quality. The report suggests that Netflix is also facing a shift in consumer viewing habits, which sees the streamer now competing with YouTube and TikTok — arguably as much as it competes with traditional TV networks now.
To court viewers drawn to short-form video, Netflix already added a TikTok-style feature called “Clips” that lets users scroll through short snippets from its library. But where Clips is designed to funnel viewers toward longer shows and movies, these new publisher deals go the other direction, bringing short-form content onto the platform in its own right.
“Members don’t just want to watch a show or film and move on — they want to keep exploring the stories and personalities they love long after the final credits roll. These partnerships help us deepen fandom and create more ways for members to carry those stories with them throughout their day,” stated John Derderian, Netflix VP of Animation Series + Kids & Family TV, who is overseeing this project.
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.
Sarah has worked as a reporter for TechCrunch since August 2011. She joined the company after having previously spent over three years at ReadWriteWeb. Prior to her work as a reporter, Sarah worked in I.T. across a number of industries, including banking, retail and software.
You can contact or verify outreach from Sarah by emailing [email protected] or via encrypted message at sarahperez.01 on Signal.
Bank of America dnes dosáhla nového historického maxima nad 60 USD za akcii před výsledky za 2. čtvrtletí. Wall Street čeká tržby 30,58 miliardy USD a EPS 1,14 USD.
Bank of America (BAC +0.23%), the second-largest bank in the U.S. by assets, hit a new all-time high today, with the stock topping $60 per share.
Many large bank stocks have had a good year thus far, particularly the investment banks, which have benefited from some massive artificial intelligence initial public offerings.
However, some of the money-center banks, such as Bank of America, have not performed as well. The stock is up about 7.5%, trailing the broader market S&P 500 Index and the Nasdaq Bank Index.
Here’s what it means ahead of second-quarter earnings.
Image source: Getty Images.
Overcoming challengesBank of America is viewed as a high-quality banking franchise, with the number one consumer bank, and strong franchises in investment banking, trading, wealth management, and commercial lending.
The Iran war, which has led to higher inflation and higher bond yields, may have derailed some of its momentum because investors are now worried about persistent inflation and whether the Federal Reserve will need to raise interest rates to ensure price stability.
Higher rates can put pressure on the credit profiles of consumers and businesses and stymie lending and investment banking activity.
Bank of America has also long grappled with balance sheet issues that stem from the pandemic, when the bank loaded up on low-yielding, long-duration bonds.
Today's Change
(
0.23
%) $
0.14
Current Price
$
60.04
The bank has nearly $915 billion in bonds still yielding 2.77%, which is depressing earnings somewhat.
Furthermore, the bank locked in nearly $515 billion of bonds into its held-to-maturity folder that are still carrying an unrealized $81 billion loss.
While Bank of America will be able to hold these bonds to maturity and avoid taking these paper losses, it’s still a drag on earnings. Higher rates would likely exacerbate the paper losses as well.
The good news is that Bank of America is just coming off one of its strongest quarters in a while in the first quarter of 2026, having delivered a 16% return on tangible common equity (ROTCE).
Net interest income, the spread revenue banks make on their lending and bond portfolios after paying funding costs, has been building in recent quarters.
Investment banking should be strong as well, given that Bank of America served as one of the five main bookrunners on the massive Space Exploration Technologies (SPCX 5.80%) IPO.
How investors should think about earningsBank of America will report its second-quarter earnings next week on July 14.
Wall Street analysts’ consensus estimates suggest the bank will report revenue of $30.58 billion and earnings per share of $1.14. That implies slight growth from the first quarter, but certainly nothing heroic.
This is not a huge surprise because large banks are mature companies at this point.
Investors will need to see the company beat estimates for the stock to rise, and credit quality, investment banking fees, and net interest income trends will also be top of mind for the market.
With Bank of America trading at a price-to-tangible-book ratio over 2x and near 10-year highs, earnings misses or minor concerns could lead to selling pressure, given the elevated valuation.
BAC Price to Tangible Book Value data by YCharts
That said, I still think Bank of America is a decent long-term investment.
Continued improvements in ROTCE can lead to a higher valuation over time, and eventually the bond portfolio will run off, boosting the company’s earnings power.
JPMorgan Chase má před výsledky za 2. čtvrtletí odhad zisku na akcii 5,49 USD při tržbách 48,71 miliardy USD. Akcie jsou letos výše o 4,9 % a blíží se rekordu.
JPMorgan Chase & Co (NYSE:JPM) is scheduled to report second-quarter earnings before the open on Tuesday, July 14, kicking off earnings season alongside several other major banks. According to Zacks Research, analysts expect earnings of $5.49 per share on revenue of $48.71 billion, representing year-over-year growth of 10.7% and 8.5%, respectively.
Options traders are pricing in a relatively modest post-earnings reaction. The options market implies a next-day move of 4.7%, though that is nearly double JPM's average post-earnings move of 2.4% over the last eight quarters. The bank has closed lower after each of its last four earnings reports, including a 4.2% drop in January.
JPMorgan stock is bucking today's broad-market weakness as chip stocks pressure the major indexes, though it has pared earlier gains, last seen up 0.2% at $338.31. The shares are on track for a fourth straight gain and are moving back toward their June 25 record high of $343.34. Longer term, there is notable support at the 320-day moving average. Year to date, the equity is up 4.9%.
Analyst sentiment could leave room for upgrades. Of the 26 brokerages covering JPMorgan, 12 carry a "buy" or "strong buy" rating, while 14 maintain "hold" recommendations, with no "sell" ratings on the books. With the shares trading just below record territory, investors will be looking to see if the bank's results and outlook can support another run at fresh highs.
Shanghai Disneyland je nejvýdělečnější mezinárodní park Disney: od otevření přinesl mateřské společnosti zisk 516,2 milionu USD. V roce 2024 navíc návštěvnost stoupla o 5 % na 14,7 milionu.
Shanghai Disneyland is Disney's highest earning international international resort. (Photo by VCG/VCG via Getty Images)
VCG via Getty Images
Disney has revealed that the total profit payout it receives from one of its theme parks outside the United States passed the $500 million mark last year making it the studio's highest-earning international outpost based on its share of the bottom line.
Surprisingly, the accolade doesn't go to Disneyland Paris even though it generates more revenue than any other Disney park outside the U.S. Instead, Shanghai Disneyland takes the crown of paying more of its profit to its parent than any other international Disney park with the total coming to an eye-watering $516.2 million since the doors to the resort swung open a decade ago.
The sprawling site on the eastern edge of Shanghai encompasses two hotels, a lake, an entertainment district and a fairytale-themed park which Disney's former chief executive Bob Iger famously described as being "authentically Disney, distinctly Chinese." There is good reason for this. Instead of creating a carbon-copy of Disney's American theme parks, its designers, who are known as Imagineers due to their imaginative use of engineering, tailored the Shanghai site to the local market. Everything was customized, from the park's layout and attraction lineup right down to its wide range of Chinese food.
It has cast a powerful spell as Shanghai Disney welcomed its 100 millionth guest in November last year and it isn't stopping there. At an event marking its tenth anniversary last month the resort announced that it is building a third on-site hotel, called the Disney Enchanted Star, with a fourth property also under development to cater for the surging demand.
According to the latest data from the Themed Entertainment Association (TEA), attendance at Shanghai Disneyland rose 5% to 14.7 million in 2024 driven by the opening of a new land themed to the Oscar-winning computer animated movie Zootopia. This made it the world's fifth most-visited theme park but the magic touch it has on Disney's bottom line has remained a closely-guarded secret. Until now.
MORE FOR YOU
Shanghai Disneyland has surged in popularity since the opening of its 'Zootopia' land. (Photo by Tang Yanjun/China News Service/VCG via Getty Images)
China News Service via Getty Images
Disney doesn't list the results of individual parks in its filings in the United States and China's companies register isn't public. However, recent filings for an obscurely-named company in the United Kingdom have lifted the curtain on the fortunes of Shanghai Disneyland.
Unlike Disney's theme parks in the United States, the resort is a public-private partnership between the media giant and China's state-owned Shanghai Shendi Group.
Disney only has a 43% stake in the company which owns the resort itself with the remainder in Shendi's hands. In contrast, Shendi is a minority shareholder in the resort's management company which is controlled by Disney through its 70% stake. In return, Disney receives royalties as well as a management fee based on the operating performance of the resort.
Disney’s shares in the resort and the management company are held by a wholly-owned subsidiary called WD Holdings (Shanghai) in Burbank, California. It pays dividends from its profits to the Disney companies which directly own it. Precisely 47% of WD Holdings is owned by The Walt Disney Company Limited in London which files publicly-available financial statements. Its latest set of filings were released recently and show that its dividends from WD Holdings began in 2019 and peaked at $57.7 million (£43.1 million) last year as I recently revealed in the Daily Mail.
This only represents 47% of the dividend so the full amount for 2025 is $122.7 million (£91.7 million) as the chart below shows. The dividend hit its lowest level in 2021 when it crashed by 60.3% to $25.9 million (£18.9 million) the midst of the pandemic. It has surged since then, thanks partly to the opening in December 2023 of the new Zootopia land. Is the first and only theme park area based on the film which was a huge hit in China.
Dividends paid by Shanghai Disneyland's holding company
MSM
A massive 23.1% of Zootopia's $1 billion box office was generated in China while a sequel last year did even better. It hauled in $630 million from China making it the highest-grossing Hollywood film in Chinese history. The theme park land capitalizes on this.
Home to a cutting-edge roving simulator ride, it is filled with brightly-colored buildings which have robotic replicas of the characters from the film peering out of their windows. Disney put more than 260 Zootopia products on sale in the park and created themed food for its restaurants. More than 532 tons of its pink paw-shaped pawpsicles alone have been sold. It has given a glow to Disney's bottom line.
'Zootopia' fans can try real-life pawpsicles in Shanghai Disneyland. (Photo by Tang Yanjun/China News Service/VCG via Getty Images)
China News Service via Getty Images
Three of its four international parks either don’t pay a dividend or only pay small sums. Disney doesn’t own its resort in Tokyo, which is run by specialist leisure operator Oriental Land Company (OLC). In return for licensing its intellectual property, OLC pays Disney royalties but not a a share of its profits. Disneyland Paris pays both but the only time it has paid out a share of its profits was in 1993 when its dividend yielded just $10.2 million (FF56.6 million) for Disney as I recently reported in The Guardian.
Likewise, Hong Kong has one of the smallest Disney parks and in 2024, following the opening of a land themed to the Oscar-winning film Frozen it made its highest-ever profit of $107.8 million (HK$838 million) which is lower than the dividend its counterpart in Shanghai paid out last year.
Shanghai's total profit payout of $516.2 million (£392.8 million) is the highest of any of Disney's international parks and doesn't even include any royalties as they are paid directly to one of its U.S. subsidiaries so they aren't shown on the U.K. filings. The total dividend for last year will actually be even higher than the amount reported in the financial statements as Disney shuffled its Shanghai shares into yet another subsidiary mid-way through 2025 and the filings for this entity are confidential.
Disney’s theme parks produced 57% of its $17.6 billion operating income and nearly 40% of its $94.4 billion revenue in 2025 which explains why the company is doubling down on them. It has earmarked $60 billion for investment in its theme park division by 2033 with a new Spider-Man themed roller coaster coming to Shanghai and a second park widely expected to get the green light as this report explained.
Nevertheless, in line with its ownership stake, it is understood that Disney covered around 43% of the estimated $5.5 billion construction cost of its resort in Shanghai so despite banking a string of blockbuster dividends from it, the studio is still waiting for its happy ending.
Bank of America obnovila pokrytí Adobe s ratingem Underperform a cílovou cenou 190 USD, protože podle ní generativní AI oslabuje konkurenceschopnost firmy. Akcie přesto v úterý vzrostly asi o 4,6 %.
Adobe Inc. ADBE shares rose about 4.6% on Tuesday even after Bank of America reinstated coverage of the software company with an Underperform rating.
The brokerage argued that generative artificial intelligence is weakening Adobe's competitive position despite the stock trading near the lower end of its historical valuation range.
Bank of America set a price target of $190, valuing the company at seven times its projected 2027 enterprise value to free cash flow (EV/FCF), below the roughly 9.7-times average multiple for a broader group of software companies.
The brokerage said Adobe's valuation alone is not sufficient to support a more constructive investment stance as the company faces increasing competition from AI-native products.
Bank of America analysts, led by Tal Liani, said the key issue facing Adobe is whether the company can accelerate growth in an AI-driven software market.
The analysts wrote that the central question is whether Adobe "can reaccelerate growth in the age of AI."
While Adobe has seen adoption of its AI offerings, the brokerage said those products have yet to generate a meaningful financial contribution.
According to the report, AI-first annual recurring revenue (ARR) currently accounts for less than 2% of Adobe's total ARR.
The bank forecasts total revenue growth slowing from 10.5% in 2025 to 8.8% in 2027, with "no clear path to near-term reacceleration."
The report also noted that AI-related competitive risks vary across Adobe's customer base.
Casual users and non-professional creators are viewed as more vulnerable because AI-generated content can often replace paid subscriptions.
Professional and enterprise customers are expected to remain more resilient because they require precision and integrated workflows.
However, the analysts cautioned that "not all professional users need the full Adobe workflow," leaving some professionals and single-application users exposed to lower-cost AI alternatives.
Leadership transition and product pressures remain in focusBank of America also highlighted challenges facing Adobe Stock, the company's marketplace for images and videos.
Management has said Adobe Stock has declined for two consecutive quarters, although it did not disclose specific figures.
The brokerage said the weakness reflects the broader risk that free or inexpensive AI tools could reduce demand for Adobe's higher-margin legacy offerings while limiting future seat expansion.
The analysts also pointed to recent executive changes as another source of uncertainty.
They said the simultaneous departures of CEO Shantanu Narayen and CFO Dan Durn "heightens risk around strategy, continuity, and leadership stability" as Adobe navigates its AI transition.
Although the bank expects Adobe to maintain strong profitability, including a free cash flow margin approaching 39% by 2028, it believes there is "limited multiple expansion without clear evidence of AI monetization and growth acceleration."
Historical data also suggests that buying large pullbacks in Adobe shares has produced inconsistent results.
Since 2010, the stock has experienced 12 declines of at least 20% within a 30-day period.
Only six of those events generated positive returns over the following year. The median one-year return after those declines was negative 4%, while investors experienced a median maximum drawdown of 17% before any recovery.
Despite that track record, Adobe's underlying financial performance remains solid.
The company reported 11.5% revenue growth over the last 12 months, with a three-year average growth rate of 11%. It also generated an operating cash flow margin of 41.6%, highlighting strong profitability and cash generation.
Creative Freemium monthly active users increased from 50 million to 90 million year over year.
Adobe currently trades at a price-to-earnings ratio of about 12, compared with roughly 25 for its peer benchmark, although Bank of America maintained that stronger evidence of AI-driven growth will be needed before adopting a more positive view on the stock.
Snowflake hlásí rychlejší adopci AI Data Cloudu, který nyní využívá více než 13 600 účtů. Firma čeká ve 2. čtvrtletí fiskálního roku 2027 růst produktových tržeb o 30 % na 1,415–1,420 miliardy USD.
Key Takeaways Snowflake AI adoption continues to grow across thousands of customer accounts. SNOW expanded enterprise AI partnerships with Thomson Reuters and Sanofi. Snowflake forecasts 30% year-over-year product revenue growth for fiscal Q2 2027. Snowflake (SNOW - Free Report) is benefiting from the accelerating adoption of its AI Data Cloud, which is fundamentally transforming how organizations leverage data and artificial intelligence to drive productivity and innovation. The rapid adoption of new AI-driven products like Snowflake Intelligence and Cortex Code (CoCo) remains noteworthy.
In the fiscal first quarter, Snowflake delivered more than 20% more product capabilities than last year. This includes new features in CoCo and Snowflake Intelligence. These products are seeing the fastest uptake in Snowflake’s history, with CoCo already in use by more than 7,100 accounts and Snowflake Intelligence more than doubling quarter over quarter. New customers such as Holiday Inn Club Vacations and Houzz selected Snowflake as the foundation for their data and AI transformation initiatives. The adoption of Snowflake AI capabilities continued to expand, with more than 13,600 accounts now leveraging these solutions.
Further expanding its AI footprint through partnerships, in June 2026, Snowflake announced that Thomson Reuters is building its enterprise AI and data platform on the Snowflake AI Data Cloud to deliver trusted, governed intelligence at scale. The collaboration enables faster analytics, modernizes legacy systems with Snowflake CoCo and supports enterprise AI innovation using Snowflake Cortex.
Snowflake also announced that Sanofi launched its “Concierge for Field,” an AI agent built with Snowflake Cortex AI to help sales representatives prepare for physician visits in seconds. The collaboration also supports Sanofi's broader deployment of AI agents across R&D, procurement, IT, HR and field sales to accelerate innovation and drug development.
Snowflake’s growing customer base, combined with its rapid product innovation, positions the company for continued upside. Snowflake expects fiscal second-quarter 2027 product revenues in the range of $1.415-$1.420 billion, implying 30% year-over-year growth.
SNOW Suffers From Stiff CompetitionSnowflake is facing stiff competition from the likes of major players like Oracle (ORCL - Free Report) and Amazon (AMZN - Free Report) , which are also expanding their footprint in the AI space.
Amazon’s AI initiatives gained significant momentum during the first quarter of 2026. Amazon’s cloud computing platform, Amazon Web Services’ chips business, including Graviton, Trainium, and Nitro, exceeded a $20 billion annual revenue run rate and is growing triple-digit percentages year over year.
Oracle’s expanding portfolio has been noteworthy. In June 2026, Oracle introduced Oracle OPERA Cloud Assistant, a suite of AI-powered capabilities built into OPERA Cloud that automates guest room assignments, generates AI-driven rate descriptions, supports multilingual operations across 230 countries and territories and gives hotel staff real-time operational guidance.
SNOW’s Share Price Performance, Valuation, and EstimatesSnowflake shares have gained 19.5% in the year-to-date period, outperforming the broader Zacks Computer & Technology sector’s increase of 14.7%. The Internet Software industry has declined 11.2% in the same time frame.
SNOW Stock Performance
Image Source: Zacks Investment Research
Snowflake stock is trading at a premium, with a forward 12-month Price/Sales ratio of 13.55X compared with the Internet Software industry’s 3.78X. SNOW has a Value Score of F.
SNOW's Valuation
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for SNOW’s fiscal 2027 earnings is pegged at $1.96 per share, which has been unchanged over the past 30 days. The figure indicates a 56.80% year-over-year increase.
Snowflake currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Key Takeaways LMND benefits from AI-led underwriting, claims automation and rising multi-policy adoption.In-force premium reached $1.33 billion, marking the 10th consecutive quarter of accelerating growth.Lemonade's reinsurance strategy, improving margins and positive free cash flow support its profitability path. Shares of Lemonade (LMND - Free Report) have gained 88.7% in the past year, outperforming the industry’s growth of 8.2%.
Strong premium growth, improving underwriting performance and continued progress toward profitability have driven the stock. Growth in in-force premium, expanding multi-policy adoption, Lemonade auto and its AI-driven platform have supported revenue growth and operating efficiency. While sustained premium growth, improving profitability and higher customer retention could support further upside, the stock's premium valuation may limit multiple expansion. The company has surpassed earnings estimates in each of the last four quarters, with an average of 25.8%.
Lemonade’s shares have outperformed its peers, including EverQuote Inc. (EVER - Free Report) and Hamilton Insurance (HG - Free Report) , which have gained 7% and 63.4%, respectively, while Root Inc. (ROOT - Free Report) has lost 46.5% in a year.
1-Year Price Performance: LMND, EVER, HG, ROOT & Industry
Image Source: Zacks Investment Research
Growth Estimates for LMNDThe Zacks Consensus Estimate for the company’s 2026 and 2027 earnings indicates a 23.6% and 49% year-over-year increase, respectively.
The consensus estimates for 2026 and 2027 revenues suggest year-over-year improvements. LMND has a Growth Score of A.
Muted Analysts' Sentiment on LMNDThe Zacks Consensus Estimate for LMND's 2026 and 2027 earnings has witnessed southbound movement, respectively, in the past 30 days.
Image Source: Zacks Investment Research
Factors in Favor of LMNDLemonade's AI-driven operating model enhances underwriting, pricing, claims automation and customer service, supporting a scalable, low-cost business model. The company's operating efficiency continues to improve, with in-force premium per employee exceeding $1 billion in the first quarter of 2026, nearly tripling over the past four years. Meanwhile, underwriting performance continues to improve, with the gross loss ratio declining despite winter storm-related losses. Disciplined underwriting and favorable prior-year reserve development drove a 159% increase in gross profit in the first quarter, reinforcing the company's path toward sustained profitability.
Pet Insurance and Lemonade Auto continue to post strong growth, while rising multi-policy adoption improves customer retention and lifetime value, supporting long-term premium growth. Its multi-product strategy enhances customer lifetime value through cross-selling opportunities while supporting a recurring, subscription-like revenue model. Strong customer retention and engagement continue to fuel growth, with management forecasting 32% revenue growth for the second quarter and 33% for full-year 2026.
Lemonade’s in-force premium (IFP) reached $1.33 billion at the end of first-quarter 2026, marking the 10th straight quarter of accelerating growth. This momentum reflects the growing contribution of its AI- and automation-driven platform, which enables efficient scaling. Customer growth and higher premiums per customer continue to drive premium expansion. Management has outlined a long-term goal of increasing IFP to $10 billion.
A major strength of the business is its reinsurance strategy, which shifts a substantial portion of claims risk to partners, helping stabilize earnings and reduce volatility. Strong premium growth and a lower reinsurance ceding rate enable the company to retain a larger share of premiums, contributing to revenues. Management expects the favorable reinsurance structure to continue supporting results through at least mid-2026.
Although profitability remains a challenge, margins are improving, free cash flow has turned positive, and management expects EBITDA profitability by the fourth quarter of 2026. Lemonade exited the first quarter with approximately $1.1 billion in cash and investments and raised its full-year 2026 outlook, reflecting confidence in sustained premium growth, improving profitability and continued business momentum.
Risks for LMNDLemonade's premium valuation remains a key concern. It trades at a 12-month trailing price-to-book ratio of 11.67X, well above the industry average of 2.96X and its three-year median of 3.97X. The elevated valuation leaves limited room for multiple expansion.
The company's results also remain exposed to catastrophe losses. Although weather-related claims were manageable in the first quarter, severe storms, hurricanes, wildfires or other catastrophic events could materially increase claims costs, pressure underwriting margins and lead to earnings volatility.
Additionally, Lemonade continues to invest heavily in customer acquisition. Sales and marketing expenses rose more than 50% year over year in the first quarter of 2026. These could weigh on margins if customer acquisition and retention fail to deliver adequate returns. While marketing efficiency remains strong, maintaining it will be important for long-term profitability.
ConclusionLemonade is well-positioned for long-term growth, supported by strong premium expansion, an AI-driven operating model and improving profitability. Its diversified product portfolio, disciplined underwriting and reinsurance strategy strengthen its competitive position. Its favorable growth estimates and positive free cash flow are other positives.
However, given a premium valuation and catastrophe exposure remain key risks, it is wise to adopt a wait-and-see approach for this Zacks Rank #3 (Hold) insurer. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Micron klesl o 7,7 % poté, co Samsung oznámil silné výsledky a zároveň uvedl, že buduje masivní továrny na polovodiče, které mohou zvýšit nabídku pamětí.
After starting the week strong, Micron (MU 5.87%) stock tumbled an unlucky 7.7% through 10:55 a.m. ET.
Blame Samsung for that.
Image source: Micron.
Korea sends the semi market South South Korean technology giant Samsung reported its Q2 2026 earnings last night. The news was objectively good -- sales up 28% sequentially, and more than double last year's Q2 revenue. Operating profit surged 19-fold, rising to $58.4 billion.
And yet Samsung stock sold off 7% today. Why?
The results beat analyst forecasts, but in a quirk of this overheated artificial intelligence-fueled stock market, investors expected Samsung to beat expectations. This triggered a "buy the rumor, sell the news" phenomenon in which investors sold Samsung stock despite its numbers being better than "expected" -- and despite Samsung confirming computer memory prices are still rising, and its profits are continuing to climb.
Today's Change
(
-5.87
%) $
-57.83
Current Price
$
926.92
What this means for Micron stock So how does all of this affect Micron, and why is it sparking a sell-off today?
Well, consider: Samsung is the world's biggest supplier of DRAM computer memory, used to make high-bandwidth memory (HBM) used in AI data centers. It's got a 38% share of the global market. SK Hynix, No. 2 in DRAM, is No. 1 in HBM with more than a 50% market share. Micron makes both NAND and DRAM memory, and its DRAM share is smaller -- about 22%, still enough for third place.
If things stay as they are, with prices rising and demand insatiable, Micron should do quite well. The problem is alongside announcing powerful profits, Samsung also said that it is building "massive semiconductor fabrication plants" to add supply to the market -- growing its market share, eating away at Micron's, and potentially closing the supply demand gap in the process.
This, in a nutshell, is why Micron stock is selling off today.
Rich Smith has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Micron Technology. The Motley Fool has a disclosure policy.
SK Hynix plánuje vstup na Nasdaq a může získat až 28 miliard USD nového kapitálu na expanzi a nákup zařízení. Firma ovládá asi 60 % trhu s HBM, který je klíčový pro AI.
SK Hynix's Nasdaq listing can not only reset the AI memory trade but also accelerate it. The company is weaponizing Wall Street to ensure it retains its leadership position in the hottest market since the AI boom started booming.
With control of approximately 60% of the high-bandwidth memory (HBM) market, which is critical for advanced computing, the opportunity is for investors to gain share in a leading memory pure-play at a discount to its peers. Estimates have SK Hynix Korean listing trading at approximately 8x forward earnings compared to Micron’s NASDAQ: MU 13.5x, suggesting an easy double-digit upside immediately upon listing.
While the upside potential for SK Hynix's U.S. listingis robust, there are a few things for investors to consider, the primary one being volatility. The listing will include the issuance of new shares, representing approximately 2.5% of the existing share count, which will provide a slight headwind for price action.
Get Micron Technology alerts:
The offset will likely be massive institutional backing, with several high-profile firms committing to large stakes. Institutional backers include Situational Awareness Partners, an investment firm founded by a former OpenAI researcher, and Coatue Management, a U.S.-based firm focused on technology.
SK Hynix Throws Down the Gauntlet, Micron Will RespondSK Hynix's U.S. listing is expected to raise as much as $28 billion in new capital. The money will be used to accelerate expansion plans and buy new equipment, both critical to meeting demand and maintaining product timelines.
The company is strengthening ties with NVIDIA NASDAQ: NVDA, ensuring it can deliver next-gen products when needed, including HBM4. HBM4 is critical to AI, as it breaks down the memory wall by enabling skyrocketing bandwidth with low power consumption, doubling the speed of HBM3 versions, and offering approximately 75% more memory capacity. The impact on AI will be tremendous.
Catalysts for SK Hynix's share price include the robust demand for HBM products, which are sold out through 2027, and pricing power. HBM memory pricing is up by high double digits, underpinning growth for SK Hynix and Micron, and is expected to remain hot for the foreseeable future. SK Hynix removed pricing caps that had been in place, allowing it to capture maximum upside while the HBM shortage persists.
Micron Technology Today
MU
Micron Technology
$922.66 -62.09 (-6.31%)
As of 02:45 PM Eastern
This is a fair market value price provided by Massive. Learn more.
52-Week Range$103.38▼
$1,255.00Dividend Yield0.07%
P/E Ratio20.90
Price Target$1,263.76
Micron, however, is not sitting idly by, allowing SK Hynix to gain share. It is actively expanding its own manufacturing capacity and HBM4 technology, including a major HBM4 hub in Japan, and realigning its die process to more closely align with NVIDIA standards so it can capture a larger share.
The likely outcome is that Micron breaks SK Hynix's near-monopoly with NVIDIA while cementing its position in the industry. Micron is also capitalizing on its unique position as the U.S.'s only domestic-based memory manufacturer, expanding facilities in Idaho and New York.
Micron May Experience Headwinds—Sell-Side Data Says Buy the DipWhile Micron’s outlook is equally bullish, there is potential for its share price action to lag SK Hynix, at least in the near- to mid-term. The risk is that investors will take profits and reduce their holdings of MU in order to shift capital into SK Hynix. In this scenario, the best-case is that MU’s stock price moves sideways within a range near existing highs, while the worst-case is that it experiences a more robust correction than it already has. Down more than 20% from its post-earnings highs as of early July, Micron’s share price could shed another 30% before hitting solid support.
The caveat is that sell-side interest, as reflected in the analysts and institutional data, remains very bullish on Micron, with a triple-strength tailwind in place. MarketBeat data reveal 38 analysts covering the name, a 92% Buy-side bias in the Buy consensus, and more than 35% upside potential relative to early-July support targets, with coverage rising, sentiment firming, and price targets trending higher over the near-, mid-, and long-term. It is not the consensus figures that matter but the trends, which are leading to the high range and suggest more than 100% is still ahead.
Micron’s stock price action reflects market strength, with a bullish MACD convergence. The MACD, or moving average convergence/divergence, measures market strength and momentum and, in this case, shows a strong, strengthening market more likely to retest its recent highs and move higher than to continue moving lower. The only question is the timing, and that may be by year’s end. Upcoming catalysts include Micron’s fiscal Q4 earnings release in September, along with reports from NVIDIA and Advanced Micro Devices NASDAQ: AMD, which are expected to confirm that AI demand continues to grow.
Should You Invest $1,000 in Micron Technology Right Now?Before you consider Micron Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Micron Technology wasn't on the list.
While Micron Technology currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Intuitive Surgical uvedla, že apendektomie má v USA adresovatelný trh zhruba 300 000 zákroků ročně. První analýzy podle firmy ukázaly, že da Vinci překonává laparoskopii v několika měřeních.
Key Takeaways ISRG sees about 300,000 U.S. appendectomies as an addressable market still being evaluated.Intuitive Surgical said early analyses showed da Vinci outperformed laparoscopy on multiple measures.ISRG expects appendectomy to lift procedure volume, though lower reimbursement may weigh on revenue mix. Although the appendectomy is in its early stages, it is emerging as one of the newest growth avenues for Intuitive Surgical’s (ISRG - Free Report) robotic surgery franchise. During the first quarter of 2026, the company highlighted continued strength in U.S. general surgery, with cholecystectomy and appendectomy procedures collectively growing 31%.
The growth was primarily supported by increasing use of da Vinci systems during after-hours and weekend surgeries. Management also noted that appendectomy represents an addressable market of roughly 300,000 annual procedures in the United States, though it is still evaluating what proportion of that market is realistically suitable for robotic surgery.
A key catalyst for broader adoption is the emergence of encouraging clinical evidence. Management stated that several institution-level analyses showed da Vinci surgery delivering superior outcomes across multiple functional measures compared with conventional laparoscopy. While these findings remain preliminary and require validation through larger clinical studies, they provide an important foundation for expanding robotic use in a procedure traditionally dominated by laparoscopic techniques.
However, reimbursement remains a meaningful constraint. Intuitive Surgical acknowledged that appendectomy is a relatively quick procedure with comparatively low reimbursement, limiting the immediate economic incentive for hospitals to adopt robotics broadly. The company believes stronger clinical evidence will be necessary before robotic appendectomy gains wider acceptance despite its promising outcomes.
From an investment perspective, appendectomy is likely to drive higher procedure volume, but the impact on margins may not be material in the near term. Higher procedure counts could increase utilization of Intuitive Surgical’s installed base, particularly during evenings and weekends, supporting recurring instrument and accessory revenues.
The lower reimbursement profile suggests the procedure may generate lower revenue per case than more complex robotic surgeries, creating a potential mix headwind. Even so, successful expansion into high-volume general surgery procedures aligns with Intuitive Surgical’s long-term strategy of broadening robotic adoption beyond its traditional specialties, reinforcing sustainable procedure growth over time.
Peer UpdatesZimmer Biomet (ZBH - Free Report) is expanding its robotic surgery opportunity by broadening both procedural indications and platform capabilities rather than relying solely on knee arthroplasty. The company has fully commercialized ROSA Shoulder, enabling robotic assistance for both anatomic and reverse shoulder replacements through glenoid reaming and humeral resection. The company is already developing a second-generation system with tighter integration into the broader ROSA digital ecosystem.
Beyond shoulders, Zimmer is preparing the semi-autonomous mBos robotic platform for a 2027 launch, positioning it as a faster, more accurate and easier-to-use system that could democratize robotic orthopedics across additional procedures. Coupled with investments in more than 200 robotic clinical specialists and continued growth of ROSA and TMINI, the company is building a multi-platform robotics portfolio designed to unlock new procedure categories and expand its addressable market.
Stryker (SYK - Free Report) is widening Mako's growth runway by transforming the platform from a knee-and-hip robot into a multifunctional orthopedic ecosystem. Following record first-quarter Mako installations, the company plans a full Mako 4 launch for shoulder surgery in mid-2026 while adding advanced hip and revision hip procedures that simplify technically demanding operations.
Management believes these new indications will increase robot utilization and ultimately drive demand for additional systems as hospitals require greater robotic capacity. Stryker is also targeting surgeons who have been hesitant to adopt full robotics through the new Mako RPS handheld system, particularly in ambulatory surgery centers, thereby expanding its customer base beyond traditional Mako users. The company indicated that more robotic indications are under development, reinforcing its strategy of creating new market opportunities through continuous procedural expansion rather than relying only on implant growth.
ISRG’s Price Performance, Valuation and EstimatesShares of ISRG have lost 23.6% so far this year compared with a 12.4% decline of the industry.
Image Source: Zacks Investment Research
From a valuation standpoint, Intuitive Surgical trades at a forward price-to-earnings ratio of 39.08X, above the industry average. But, it is still lower than its five-year median of 69.80X. ISRG carries a Value Score of D.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Intuitive Surgical’s 2026 earnings implies a 16.6% rise from the year-ago period’s level.
Image Source: Zacks Investment Research
The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
MercadoLibre dál roste, tržby meziročně stouply o více než 30 % na 29 miliard USD. Investoři ale řeší nižší ziskovost, protože čistá marže klesla z 10,5 % ve 4. čtvrtletí 2024 na 6,4 % ve 4. čtvrtletí 2025.
When investors think about MercadoLibre (MELI +1.11%), they typically think of one of the world's best growth stories. The company has spent years building Latin America's leading e-commerce marketplace, while simultaneously growing Mercado Pago into one of the region's largest digital financial platforms.
Yet, despite another year of impressive operating results, the stock hasn't rewarded investors as it once did. So what's happening?
The answer isn't slowing growth. It's that investors have become increasingly concerned about MercadoLibre's cost of maintaining that growth.
Image source: Getty Images.
Growth isn't the problem By almost every operating measure, MercadoLibre is executing exceptionally well. Revenue has grown by more than 30% year over year to $29 billion, supported by healthy increases in gross merchandise volume, unique buyers, and payment volume.
Payments platform Mercado Pago is attracting new users while expanding deeper into lending, investments, and digital banking. Meanwhile, the company is investing billions of dollars to strengthen its logistics network and payments infrastructure across Brazil, Mexico, and Argentina.
These aren't the numbers of a business that's losing momentum. Instead, they reinforce the same long-term investment thesis that has driven MercadoLibre's success for years: Latin America's digital economy remains underpenetrated, and the company continues to strengthen its leadership position.
If growth were the only thing investors cared about, MercadoLibre's stock would probably be performing much better.
Today's Change
(
1.11
%) $
19.99
Current Price
$
1,825.67
Investors are becoming less tolerant of lower margins Instead, the market's attention has shifted to profitability.
During 2025, MercadoLibre increased spending on logistics, lowered free-shipping thresholds in Brazil, and leaned more heavily on promotions to defend its competitive position. Those investments helped drive higher engagement and transaction volumes, but they also weighed on operating margins. For perspective, net margin has fallen from 10.5% in the fourth quarter of 2024 to 6.4% in the fourth quarter of 2025.
That has created a different debate among investors. The question is no longer whether MercadoLibre can continue growing. It's whether that growth is becoming more expensive.
This distinction matters because companies can grow revenue for years while delivering disappointing shareholder returns -- if profitability fails to keep pace. In short, investors have become increasingly focused on whether MercadoLibre can eventually convert its scale into stronger earnings and free cash flow.
Competition has intensified in recent years Part of that concern stems from a more competitive landscape.
Shopee, a subsidiary of Sea Limited, has continued expanding aggressively in Brazil through shipping subsidies, attractive seller incentives, and low prices. Another newcomer, Temu, a subsidiary of PDD Holdings, has reset consumer expectations by offering ultra-cheap products shipped directly from China. On the fintech side, Nu Holdings is competing for consumers' wallets and financial relationships.
None of these companies individually poses a threat to MercadoLibre's leadership. Collectively, however, they force MercadoLibre to invest more aggressively to defend its ecosystem. For perspective, the company aims to invest $11 billion in its Brazilian market in 2026, up 50% from 2025.
That has important implications for investors. Competition doesn't have to reduce MercadoLibre's market share to affect the business. Just defending its leadership may require permanently higher logistics spending, more promotions, or lower seller fees, which could impact the company's long-term profitability.
What does it mean for investors? MercadoLibre remains one of the strongest businesses in Latin America. Its marketplace, logistics network, and fintech ecosystem reinforce one another, creating competitive advantages that few companies in the region can match.
But the stock is no longer being judged solely on growth. Investors also want proof that MercadoLibre can translate its expanding ecosystem into improving profitability. Until that happens, the stock may continue to experience volatility, even as the underlying business scales. Long-term investors need to be aware of this.
Strategy prodala část bitcoinů poprvé od roku 2022, aby financovala dividendy na preferenční akcie. Po prodeji držela 843 775 bitcoinů a 2,55 miliardy USD v hotovosti.
What Strategy’s July 6 Filing Actually Says About Its First Major Bitcoin Sale Since 2022
The filing is specific. The coins went in two tranches: 1,363 bitcoin between June 29 and June 30, then 2,225 between July 1 and July 5 at an average of roughly $60,773. The proceeds funded quarterly dividends on four preferred series, STRF, STRE, STRK and STRD, plus the semi-monthly dividend on STRC.
The uncomfortable number is the cost basis. Strategy’s average purchase price is about $75,476 a coin, so it sold below cost, realizing a loss to raise cash. After the sale it held 843,775 bitcoin and $2.55 billion in cash.
Why A Small Sale Is A Big SignalFor years the model was simple: issue securities, buy bitcoin, never sell. This sale confirms that has changed. Strategy adopted a framework that permits sales to meet obligations — the reason is the preferred stack: those dividends, roughly $1.6 billion a year, are a standing cash call the software business cannot cover, and the sale recasts the dividend-and-capital-structure story around the coins.
The Two SidesThe bull case is that the sale is tiny, roughly 0.4% of holdings, the balance sheet still carries $2.55 billion in cash, and the same preferreds raised the capital that bought the bitcoin in the first place. This is not a solvency event.
The Bottom LineThe disclosure is small in size and large in signal: Strategy’s dividend obligations now shape its treasury decisions. For anyone following MSTR, the variable to track is the preferred dividend run-rate against cash and the company’s ability to issue equity, because that, more than the bitcoin price alone, now decides whether Strategy is a buyer or a seller.
Disclosure: The author holds no position in Strategy and no position in bitcoin.
Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga’s reporting and has not been edited for content or accuracy.
Market News and Data brought to you by Benzinga APIs
Cloudflare vzrostl v úterý o 7 % poté, co Scotiabank zvýšila rating na Sector Outperform ze Sector Perform a cílovou cenu na 300 USD. Banka vidí rostoucí roli firmy v AI infrastruktuře.
Cloudflare Inc. NET shares climbed 7% on Tuesday after Scotiabank upgraded the cloud infrastructure and cybersecurity company, citing growing confidence in its long-term role in artificial intelligence infrastructure and raising its price target on the stock.
The brokerage upgraded Cloudflare to Sector Outperform from Sector Perform and increased its price target to $300 from $225, pointing to multiple catalysts that it believes could drive stronger revenue growth over the coming quarters.
Shares of Cloudflare rose after the analyst report, adding to investor optimism surrounding the company's expanding role in AI infrastructure and developer tools.
Scotiabank analyst Patrick Colville said Cloudflare's Workers platform is increasingly becoming a preferred infrastructure layer for AI-generated, or "vibe coded," applications, including OpenAI Codex Sites and Lovable.
"We upgrade our rating on the common shares of Cloudflare to Sector Outperform and lift our price target to $300," Colville said.
After spending the past 4+ weeks doing a deeper dive on Cloudflare's opportunity, we feel convinced that the time is now to own NET as: (1) Workers is becoming the default infrastructure for vibe coded applications – including OpenAI Codex Sites and Lovable, a dynamic we think is underappreciated by investors; (2) Traffic trends, which typically precede revenue by 3 quarters are inflecting due to agentic AI and will set Cloudflare up nicely to beat and raise Street numbers by ~5pp in 2H26, (3) Cloudflare is winning the best of the best AI-native customers, which validates their architecture and provides a long runway for growth.
According to Scotiabank, these developments are not yet fully reflected in investor expectations and could become an increasingly important driver of Cloudflare's future growth.
The brokerage also pointed to the company's ability to attract leading AI-native customers, saying this validates its technology platform and supports a longer runway for expansion.
Scotiabank said Cloudflare's traffic growth has historically preceded revenue growth by approximately three quarters and noted that those trends are now accelerating as demand for agentic AI applications increases.
The firm believes the improvement in traffic could allow Cloudflare to outperform Wall Street expectations by roughly five percentage points during the second half of 2026.
The report argues that stronger traffic trends, combined with growing adoption of AI-focused applications, position the company for improved financial performance over the coming quarters.
The analyst note follows Cloudflare's July 1 launch of Monetization Gateway, which expands its existing Pay Per Crawl service into Pay Per Use through the open x402 protocol.
The initiative is designed to allow website owners to charge AI agents for access on a per-use basis, supporting what the company describes as the emerging agentic web.
The feature remains in an early-access and waitlist phase.
While acknowledging that Cloudflare continues to trade at a premium valuation, Scotiabank said the company's long-term opportunity in AI infrastructure is becoming increasingly clear.
The brokerage argued that the combination of growing AI adoption, improving traffic trends and continued product development supports a more constructive outlook for the stock despite its elevated valuation.
Cloudflare trades at a forward P/E of 204.19, according to data from stockanalysis.
Key Takeaways Cameco halted Cigar Lake mining after Orano's McClean Lake mill's sulfuric acid plant shut down.Operations at McClean Lake are expected to resume in two weeks, with no current impact on 2026 guidance.Cigar Lake produced 19.1 million pounds in 2025, with Cameco's share at 10.4 million pounds. Cameco Corporation (CCJ - Free Report) has temporarily suspended operations at Cigar Lake mine, citing operational issues at Orano’s McClean Lake mill, where Cigar Lake ore is processed. The mill is expected to resume operations in two weeks, and the company does not currently anticipate any impact on its 2026 production guidance for Cigar Lake. However, any prolonged outage at the McClean Lake mill could prompt a reassessment of that outlook.
The disruption stems from problems at the mill's sulfuric acid plant, which was forced to shut down for repairs. Orano is working to restore the acid plant and is also evaluating alternative sources of sulfuric acid while it awaits replacement parts. With limited ore storage capacity at Cigar Lake, mining activities had to be stalled until sufficient acid was available to allow milling to resume at McClean Lake.
Cameco increased its ownership stake in Cigar Lake to 57.418%. Located in northern Saskatchewan, Canada, Cigar Lake is widely recognized for its exceptionally high-grade ore body and long reserve life, making it one of the most valuable uranium mines globally.
In 2025, the mine produced 19.1 million pounds, with Cameco’s attributable share at 10.4 million pounds. For 2026, Cigar Lake is expected to produce between 17.5 million and 18.0 million pounds on a 100% basis. Based on Cameco's previous ownership interest of 54.547%, its attributable production was projected at 9.5-10.0 million pounds. Following the recent increase in ownership, the company is expected to update its attributable production outlook to reflect the same.
This is the second operational disruption Cameco has faced this year. In May, the company temporarily suspended operations at its McArthur River mine and Key Lake mill after severe flooding in northern Saskatchewan caused a partial collapse of the Smoothstone River Bridge, a critical transportation route used to deliver supplies to the sites. Cameco quickly established an alternative logistics route, restoring the flow of essential materials and enabling both operations to return to full production within a short period.
Despite the interruption, Cameco maintained the 2026 guidance for uranium production of 14.0-16.5 million pounds from the McArthur River and Key Lake operations, with its attributable share at 10-11.5 million pounds. The company expects consolidated attributable uranium production of 19.5-21.5 million pounds in 2026.
CCJ’s Price Performance, Valuation & EstimatesCameco shares have gained 30% in a year compared with the industry’s 22.6% growth. Uranium peers Energy Fuels Inc. (UUUU - Free Report) and Uranium Energy (UEC - Free Report) have gained 120.4% and 57%, respectively.
Image Source: Zacks Investment Research
CCJ stock is trading at a forward price-to-sales multiple of 16.67X compared with the industry’s 5.42X. Energy Fuels is currently trading at a forward price-to-sales ratio of 18.59X and Uranium Energy is trading at a loftier 59.76X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Cameco’s earnings for fiscal 2026 indicates year-over-year growth of 17.5%. The same for 2027 implies growth of 58.8%.
Image Source: Zacks Investment Research
While the consensus estimate for 2026 earnings has moved down over the past 60 days, the same for 2027 has remianed unchanged, as shown in the chart below.
Image Source: Zacks Investment Research
The company currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
